0001558370-23-014913.txt : 20230814 0001558370-23-014913.hdr.sgml : 20230814 20230814170335 ACCESSION NUMBER: 0001558370-23-014913 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XCel Brands, Inc. CENTRAL INDEX KEY: 0001083220 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 760307819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37527 FILM NUMBER: 231171777 BUSINESS ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (347) 727-2474 MAIL ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: NETFABRIC HOLDINGS, INC DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: HOUSTON OPERATING CO DATE OF NAME CHANGE: 19990402 10-Q 1 xelb-20230630x10q.htm 10-Q
0.290.1819633194195711190001083220--12-312023Q2false001970065619624860P6YP25YP20YP10YP25YP20YP25YP5YP5YP5YP5YP5Y6M0001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-310001083220xelb:HalstonBrandMembersrt:MinimumMember2023-05-152023-05-150001083220xelb:HalstonBrandMembersrt:MaximumMember2023-05-152023-05-150001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-312022-05-310001083220xelb:ImWhpLlcMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-06-012023-06-300001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-312022-05-3100010832202023-07-012023-10-310001083220us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-01-012023-06-3000010832202023-05-012023-05-310001083220xelb:HalstonBrandMember2023-01-012023-06-300001083220us-gaap:WarrantMember2022-01-012022-12-310001083220xelb:LoriGoldsteinBrandMember2021-04-012021-04-010001083220xelb:LoriGoldsteinBrandMember2023-01-012023-06-300001083220xelb:LoriGoldsteinBrandMember2022-01-012022-12-3100010832202022-01-012022-12-310001083220xelb:ImWhpLlcMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2023-06-300001083220xelb:HalstonBrandMember2023-05-152023-05-150001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:QOptixLlcMember2023-01-012023-06-300001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2023-01-012023-06-300001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2022-04-012022-06-300001083220srt:DirectorMemberus-gaap:CommonStockMember2022-04-012022-06-300001083220us-gaap:CommonStockMember2023-04-012023-06-300001083220us-gaap:CommonStockMember2023-01-012023-03-310001083220us-gaap:CommonStockMember2022-04-012022-06-300001083220us-gaap:RetainedEarningsMember2023-06-300001083220us-gaap:NoncontrollingInterestMember2023-06-300001083220us-gaap:AdditionalPaidInCapitalMember2023-06-300001083220us-gaap:RetainedEarningsMember2023-03-310001083220us-gaap:NoncontrollingInterestMember2023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-03-3100010832202023-03-310001083220us-gaap:RetainedEarningsMember2022-12-310001083220us-gaap:NoncontrollingInterestMember2022-12-310001083220us-gaap:AdditionalPaidInCapitalMember2022-12-310001083220us-gaap:RetainedEarningsMember2022-06-300001083220us-gaap:NoncontrollingInterestMember2022-06-300001083220us-gaap:AdditionalPaidInCapitalMember2022-06-300001083220us-gaap:RetainedEarningsMember2022-03-310001083220us-gaap:NoncontrollingInterestMember2022-03-310001083220us-gaap:AdditionalPaidInCapitalMember2022-03-3100010832202022-03-310001083220us-gaap:RetainedEarningsMember2021-12-310001083220us-gaap:NoncontrollingInterestMember2021-12-310001083220us-gaap:AdditionalPaidInCapitalMember2021-12-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001083220xelb:ConsultantsMember2022-04-012022-06-300001083220us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:CommonStockMember2022-04-012022-06-300001083220srt:ExecutiveOfficerMemberus-gaap:CommonStockMember2022-04-012022-06-300001083220us-gaap:CommonStockMember2023-06-300001083220us-gaap:CommonStockMember2023-03-310001083220us-gaap:CommonStockMember2022-12-310001083220us-gaap:CommonStockMember2022-06-300001083220us-gaap:CommonStockMember2022-03-310001083220us-gaap:CommonStockMember2021-12-310001083220us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001083220us-gaap:EmployeeStockOptionMember2022-12-310001083220us-gaap:EmployeeStockOptionMember2023-06-300001083220us-gaap:EmployeeStockOptionMember2022-12-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-03-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2011Member2023-06-300001083220us-gaap:RestrictedStockMember2022-12-310001083220xelb:ConsultantMemberus-gaap:CommonStockMember2023-05-152023-05-150001083220xelb:ConsultantMemberus-gaap:CommonStockMember2023-04-172023-04-170001083220xelb:ConsultantMemberus-gaap:CommonStockMember2023-01-012023-01-010001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-06-300001083220srt:MaximumMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-04-012023-06-300001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-01-012023-06-300001083220xelb:ImTopcoMemberus-gaap:RelatedPartyMemberxelb:ServicesAgreementMember2023-04-012023-06-300001083220xelb:ImTopcoMemberus-gaap:RelatedPartyMemberxelb:ServicesAgreementMember2023-01-012023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-04-012023-06-300001083220us-gaap:ProductMember2023-04-012023-06-300001083220us-gaap:LicenseMember2023-04-012023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-06-300001083220xelb:HalstonBrandMemberus-gaap:LicenseMember2023-01-012023-06-300001083220us-gaap:ProductMember2023-01-012023-06-300001083220us-gaap:LicenseMember2023-01-012023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-06-300001083220us-gaap:ProductMember2022-04-012022-06-300001083220us-gaap:LicenseMember2022-04-012022-06-300001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-06-300001083220us-gaap:ProductMember2022-01-012022-06-300001083220us-gaap:LicenseMember2022-01-012022-06-300001083220us-gaap:RetainedEarningsMember2023-04-012023-06-300001083220us-gaap:NoncontrollingInterestMember2023-04-012023-06-300001083220us-gaap:RetainedEarningsMember2023-01-012023-03-310001083220us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2022-04-012022-06-300001083220us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001083220us-gaap:RetainedEarningsMember2022-01-012022-03-310001083220us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001083220xelb:ImTopcoMemberus-gaap:RelatedPartyMemberxelb:ServicesAgreementMember2022-05-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-06-300001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-06-300001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-06-300001083220xelb:IMTopcoLLCMember2022-05-310001083220xelb:IMTopcoLLCMember2023-04-012023-06-300001083220xelb:IMTopcoLLCMember2023-01-012023-06-300001083220xelb:IMTopcoLLCMember2023-04-012023-06-300001083220xelb:IMTopcoLLCMember2023-01-012023-06-300001083220us-gaap:OtherExpenseMember2023-01-012023-06-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-01-012022-06-300001083220us-gaap:TrademarksMember2023-06-300001083220us-gaap:IntellectualPropertyMember2023-06-300001083220us-gaap:TrademarksMember2022-12-310001083220us-gaap:IntellectualPropertyMember2022-12-310001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-270001083220us-gaap:RestrictedStockMember2023-01-012023-06-300001083220us-gaap:EmployeeStockOptionMember2023-06-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2023-05-272023-05-270001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2023-05-270001083220xelb:HalstonBrandMember2023-06-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-04-012023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-06-300001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-06-300001083220us-gaap:RestrictedStockMember2023-06-300001083220us-gaap:EmployeeStockOptionMemberxelb:EquityIncentivePlan2021Member2023-06-300001083220xelb:EquityIncentivePlan2021Member2023-06-300001083220us-gaap:WarrantMember2023-06-300001083220us-gaap:WarrantMember2022-12-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-150001083220xelb:HalstonBrandMember2023-05-1500010832202022-06-3000010832202021-12-310001083220xelb:LoriGoldsteinBrandMember2023-06-300001083220xelb:LoriGoldsteinBrandMember2022-12-310001083220us-gaap:WarrantMember2023-04-012023-06-300001083220us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001083220us-gaap:WarrantMember2023-01-012023-06-300001083220us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001083220us-gaap:WarrantMember2022-04-012022-06-300001083220us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001083220us-gaap:WarrantMember2022-01-012022-06-300001083220us-gaap:EmployeeStockOptionMember2022-01-012022-06-3000010832202022-04-012023-06-3000010832202022-01-012023-06-300001083220us-gaap:WarrantMember2023-04-012023-06-300001083220us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001083220us-gaap:CommonStockMember2023-04-012023-06-300001083220us-gaap:WarrantMember2023-01-012023-06-300001083220us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001083220us-gaap:CommonStockMember2023-01-012023-06-300001083220xelb:NonManagementDirectorsMember2022-04-012022-06-300001083220xelb:EmployeeMember2022-04-012022-06-300001083220xelb:CostsAndExpensesMember2022-04-012022-06-300001083220us-gaap:WarrantMember2022-04-012022-06-300001083220us-gaap:OtherIncomeMember2022-04-012022-06-300001083220us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001083220us-gaap:CommonStockMember2022-04-012022-06-300001083220xelb:NonManagementDirectorsMember2022-01-012022-06-300001083220xelb:EmployeeMember2022-01-012022-06-300001083220xelb:CostsAndExpensesMember2022-01-012022-06-300001083220us-gaap:WarrantMember2022-01-012022-06-300001083220us-gaap:OtherIncomeMember2022-01-012022-06-300001083220us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001083220us-gaap:CommonStockMember2022-01-012022-06-3000010832202022-01-012022-06-300001083220us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000010832202023-04-012023-06-300001083220us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100010832202023-01-012023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000010832202022-04-012022-06-300001083220us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100010832202022-01-012022-03-310001083220us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001083220srt:ExecutiveOfficerMemberus-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001083220us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-04-012022-06-300001083220srt:ExecutiveOfficerMember2022-04-012022-06-300001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-06-300001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-12-3100010832202023-06-3000010832202022-12-3100010832202023-08-0900010832202023-01-012023-06-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purexelb:item

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

or

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

For the transition period from ___ to ___

Commission File Number: 001-37527

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

76-0307819

(State or Other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

 

1333 Broadway, 10th Floor, New York, NY 10018

 

 

(Address of Principal Executive Offices)

 

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, $0.001 par value per share

XELB

NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes         No   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes       No   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company   

 

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes       No   

As of August 9, 2023, there were 19,707,956 shares of common stock, $.001 par value per share, of the issuer outstanding.

XCEL BRANDS, INC.

INDEX

a

Page

PART I - FINANCIAL INFORMATION

3

Item 1.

Financial Statements

3

Unaudited Condensed Consolidated Balance Sheets

3

Unaudited Condensed Consolidated Statements of Operations

4

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

5

Unaudited Condensed Consolidated Statements of Cash Flows

6

Notes to Unaudited Condensed Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

31

Item 4.

Controls and Procedures

31

PART II - OTHER INFORMATION

31

Item 1.

Legal Proceedings

31

Item 1A.

Risk Factors

31

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 3.

Defaults Upon Senior Securities

31

Item 4.

Mine Safety Disclosures

32

Item 5.

Other Information

32

Item 6.

Exhibits

32

Signatures

32

2

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

    

June 30, 2023

    

December 31, 2022

(Unaudited)

(Note 1)

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

3,507

$

4,608

Accounts receivable, net

 

6,878

 

5,110

Inventory

 

798

 

2,845

Prepaid expenses and other current assets

 

554

 

1,457

Total current assets

 

11,737

 

14,020

Non-current Assets:

Property and equipment, net

 

916

 

1,418

Operating lease right-of-use assets

4,946

5,420

Trademarks and other intangibles, net

 

44,590

 

47,665

Equity method investment

18,165

19,195

Deferred tax assets, net

1,107

1,107

Other assets

 

25

 

110

Total non-current assets

 

69,749

 

74,915

Total Assets

$

81,486

$

88,935

Liabilities and Stockholders' Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable, accrued expenses and other current liabilities

$

2,750

$

3,870

Deferred revenue

 

922

 

88

Accrued income taxes payable

555

568

Accrued payroll

 

154

 

416

Current portion of operating lease obligations

1,219

1,376

Current portion of contingent obligations

 

1,400

 

243

Total current liabilities

 

7,000

 

6,561

Long-Term Liabilities:

 

  

 

  

Long-term portion of operating lease obligations

4,660

5,839

Deferred revenue

4,207

Long-term portion of contingent obligations

4,996

6,396

Total long-term liabilities

 

13,863

 

12,235

Total Liabilities

 

20,863

 

18,796

Commitments and Contingencies

 

  

 

  

Stockholders' Equity:

 

  

 

  

Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding

 

 

Common stock, $.001 par value, 50,000,000 shares authorized, and 19,700,656 and 19,624,860 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively

 

20

 

20

Paid-in capital

 

103,715

 

103,592

Accumulated deficit

 

(41,908)

 

(32,797)

Total Xcel Brands, Inc. stockholders' equity

 

61,827

 

70,815

Noncontrolling interest

(1,204)

(676)

Total Stockholders' Equity

 

60,623

 

70,139

Total Liabilities and Stockholders' Equity

$

81,486

$

88,935

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

3

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

For the Three Months Ended

For the Six Months Ended

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Revenues

 

  

 

  

  

 

  

Net licensing revenue

$

2,428

$

5,175

$

4,650

$

11,136

Net sales

 

4,353

 

3,292

 

8,181

 

6,078

Net revenue

 

6,781

 

8,467

 

12,831

 

17,214

Cost of goods sold

 

3,800

 

2,570

 

6,493

 

4,250

Gross profit

 

2,981

 

5,897

 

6,338

 

12,964

Direct operating costs and expenses

 

  

 

  

 

  

 

  

Salaries, benefits and employment taxes

 

2,241

 

5,236

 

5,706

 

10,089

Other selling, general and administrative expenses

 

2,943

 

4,288

 

6,436

 

7,712

Total direct operating costs and expenses

 

5,184

 

9,524

 

12,142

 

17,801

Operating loss before other operating costs and expenses (income)

(2,203)

(3,627)

(5,804)

(4,837)

Other operating costs and expenses (income)

Depreciation and amortization

 

1,786

 

1,812

 

3,583

 

3,632

Gain on sale of majority interest in Isaac Mizrahi brand

(20,608)

(20,608)

Loss from equity method investment

515

1,030

Gain on sale of limited partner ownership interest

(351)

(351)

Gain on settlement of lease liability

(445)

(445)

Operating (loss) income

 

(3,708)

 

15,169

 

(9,621)

 

12,139

Interest and finance (income) expense

 

  

 

  

 

  

 

  

Interest expense - term loan debt

 

 

479

 

 

1,187

Other interest and finance charges, net

 

(7)

 

(1)

 

18

 

Loss on early extinguishment of debt

2,324

2,324

Total interest and finance (income) expense

 

(7)

 

2,802

 

18

 

3,511

(Loss) income before income taxes

 

(3,701)

 

12,367

 

(9,639)

 

8,628

Income tax (benefit) provision

 

 

3,178

 

 

3,178

Net (loss) income

(3,701)

9,189

(9,639)

5,450

Net loss attributable to noncontrolling interest

(233)

(301)

(528)

(553)

Net (loss) income attributable to Xcel Brands, Inc. stockholders

$

(3,468)

$

9,490

$

(9,111)

$

6,003

(Loss) earnings per common share attributable to Xcel Brands, Inc. stockholders:

 

  

 

  

 

  

 

  

Basic net (loss) income per share

$

(0.18)

$

0.48

$

(0.46)

$

0.31

Diluted net (loss) income per share

$

(0.18)

$

0.48

$

(0.46)

$

0.30

Weighted average number of common shares outstanding:

 

  

 

  

 

  

 

  

Basic weighted average common shares outstanding

 

19,735,500

 

19,677,243

 

19,684,630

 

19,624,474

Diluted weighted average common shares outstanding

 

19,735,500

 

19,814,448

 

19,684,630

 

19,756,775

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

4

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

Xcel Brands, Inc. Stockholders

Common Stock

Number of

Paid-In

Accumulated

Noncontrolling

Total

    

Shares

    

Amount

    

Capital

    

Deficit

    

Interest

Equity

Balance as of December 31, 2021

 

19,571,119

$

20

$

103,039

$

(28,779)

$

662

$

74,942

Compensation expense related to stock options and restricted stock

30

30

Net loss

 

 

 

 

(3,487)

(252)

 

(3,739)

Balance as of March 31, 2022

 

19,571,119

20

103,069

(32,266)

410

71,233

Compensation expense related to stock options and restricted stock

402

402

Shares issued to executive related to stock grants for bonus payments

 

178,727

 

 

281

 

 

 

281

Shares repurchased from executive in exchange for withholding taxes

 

(53,882)

 

 

(85)

 

 

 

(85)

Shares issued to consultant in connection with stock grant

20,064

33

 

33

Shares issued to directors in connection with restricted stock grants

50,000

Shares issued to consultant in connection with Isaac Mizrahi sale transaction

65,275

97

 

97

Shares issued to key employee in connection with stock grant

33,557

50

 

50

Shares repurchased from key employee in exchange for withholding taxes related to vesting of restricted shares

(240,000)

(357)

 

(357)

Net income (loss)

 

 

 

 

9,490

 

(301)

 

9,189

Balance as of June 30, 2022

 

19,624,860

$

20

$

103,490

$

(22,776)

$

109

$

80,843

Balance as of December 31, 2022

 

19,624,860

$

20

$

103,592

$

(32,797)

$

(676)

$

70,139

Compensation expense related to stock options and restricted stock

51

51

Shares issued to consultant in connection with stock grant

 

8,334

 

 

6

 

 

 

6

Net loss

 

 

 

 

(5,643)

(295)

 

(5,938)

Balance as of March 31, 2023

 

19,633,194

20

103,649

(38,440)

(971)

64,258

Compensation expense related to stock options and restricted stock

27

27

Shares issued to consultant in connection with stock grant

 

58,334

 

 

39

 

 

 

39

Shares issued on exercise of stock options, net of shares surrendered for cashless exercises

9,128

Net loss

 

 

 

 

(3,468)

 

(233)

 

(3,701)

Balance as of June 30, 2023

 

19,700,656

$

20

$

103,715

$

(41,908)

$

(1,204)

$

60,623

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

5

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

For the Six Months Ended June 30, 

    

2023

    

2022

Cash flows from operating activities

 

  

 

  

Net (loss) income

$

(9,639)

$

5,450

Adjustments to reconcile net (loss) income to net cash used in operating activities:

 

 

  

Depreciation and amortization expense

 

3,583

 

3,632

Asset impairment charges

 

100

 

Amortization of deferred finance costs included in interest expense

 

 

156

Stock-based compensation

 

122

 

517

Provision for doubtful accounts

90

Undistributed proportional share of net loss of equity method investee

1,030

Loss on early extinguishment of debt

2,324

Deferred income tax provision

 

 

1,384

Gain on sale of majority interest in Isaac Mizrahi brand

(20,608)

Gain on sale of limited partner ownership interest

(351)

Gain on settlement of lease liability

(445)

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(1,768)

 

(1,741)

Inventory

 

2,047

 

(100)

Prepaid expenses and other current and non-current assets

 

863

 

8

Deferred revenue

5,041

347

Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities

 

(1,637)

 

205

Lease-related assets and liabilities

(417)

(159)

Other liabilities

 

 

(224)

Net cash used in operating activities

 

(1,471)

 

(8,719)

Cash flows from investing activities

 

  

 

  

Net proceeds from sale of majority interest in Isaac Mizrahi brand

45,408

Net proceeds from sale of assets

451

Purchase of property and equipment

 

(81)

 

(85)

Net cash provided by investing activities

 

370

 

45,323

Cash flows from financing activities

 

  

 

  

Shares repurchased including vested restricted stock in exchange for withholding taxes

 

(442)

Payment of long-term debt

 

 

(29,000)

Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt

(1,511)

Net cash used in financing activities

 

 

(30,953)

Net (decrease) increase in cash and cash equivalents

 

(1,101)

 

5,651

Cash and cash equivalents at beginning of period

4,608

5,222

Cash and cash equivalents at end of period

$

3,507

$

10,873

Supplemental disclosure of cash flow information:

 

  

 

  

Cash paid during the period for interest

$

$

1,032

Cash paid during the period for income taxes

$

16

$

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

6

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2022 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023.

The Company is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company manages the Q Optix business through its 50% ownership interest in Q Optix, LLC; the Company consolidates Q Optix, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a 30% ownership interest in IM Topco, LLC, and continues to contribute to the operations of the brand through a service agreement (see Note 11 for additional details). The Company accounts for its interest in IM Topco, LLC using the equity method of accounting.

7

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

The Company designs, produces, markets, and distributes products, licenses its brands to third parties, and generates licensing revenues through contractual arrangements with manufacturers and retailers. The Company and its licensees distribute through an omni-channel retail sales strategy, which includes distribution through interactive television, digital live-stream shopping, wholesale, and e-commerce channels to be everywhere its customers shop.

The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Condensed Consolidated Statements of Operations, separately from the Company’s net licensing revenue.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $3.5 million and $9.1 million during the three and six months ended June 30, 2023, respectively (which included net non-cash expenses of approximately $1.7 million and $4.0 million, respectively), and had an accumulated deficit of approximately $41.9 million as of June 30, 2023. Net cash used in operating activities was approximately $1.5 million for the six months ended June 30, 2023. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent obligations payable in common stock) of approximately $6.0 million as of June 30, 2023. The Company’s cash and cash equivalents were approximately $3.5 million as of June 30, 2023. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

Management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2023 and beyond. For the Halston Brand, on May 15, 2023, the Company entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 4). This new master license for the Halston Brand provides for an upfront cash payment and royalties, including certain guaranteed minimum royalties to the Company, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

The transition of these operating businesses was substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of June 30, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses by approximately $7 million, on an annualized basis when compared to the corresponding periods in the prior year.

Based on these recent events and changes in the Company’s business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of June 30, 2023, have been alleviated.

8

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

2.      Equity Method Investment

IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

The purchase price paid by WHP to the Company at the closing of the transaction consisted of $46.2 million in cash. The Company incurred approximately $0.9 million of expenses directly related to this transaction, including legal fees and agent fees, of which $0.1 million of the agent fees were paid through the issuance of 65,275 shares of the Company’s common stock, which were recognized as a reduction to the gain from the transaction. The Company recognized a net pre-tax gain from the transaction of $20.6 million, which is classified within “other expense (income), including non-cash expenses” in the condensed consolidated statements of operations for the three and six months ended June 30, 2022.

The Company accounts for its 30% interest in the ongoing operations of IM Topco as other expense (income) under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective percentage interests.

Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million and $1.03 million related to its investment for the three and six months ended June 30, 2023, respectively. The Company did not recognize any equity income or loss related to its investment for the three and six months ended June 30, 2022.

9

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

Summarized financial information for IM Topco for the three and six months ended June 30, 2023 is as follows:

    

For the three

    

For the six

months ended

months ended

June 30,

June 30,

($ in thousands)

2023

2023

Revenues

$

3,573

$

6,919

Gross profit

3,573

6,919

Income from continuing operations

206

113

Net income

206

113

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

June 30, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

24,391

 

44,489

Copyrights and other intellectual property

 

8 years

 

429

 

328

 

101

Total

$

69,309

$

24,719

$

44,590

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

Amortization expense for intangible assets was approximately $1.54 million for both the three-month period ended June 30, 2023 (the "current quarter") and the three-month period ended June 30, 2022 (the "prior year quarter").

Amortization expense for intangible assets was approximately $3.07 million for both the six-month period ended June 30, 2023 (the "current six months") and the six-month period ended June 30, 2022 (the "prior year six months").

4.      Significant Contracts and Concentrations

Halston Master License

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. The licensee has

10

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.89 million of deferred revenue contract liabilities on its condensed consolidated balance sheet as of June 30, 2023 related to this contract, of which $0.89 million was classified as a current liability and $4.00 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 5.5 years. Net licensing revenue recognized from the Halston Master License was $0.33 million for the current quarter and current six months.

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.76 million and $4.05 million for the current quarter and prior year quarter, respectively, representing approximately 26% and 48% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year quarter included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.
Net licensing revenue from the Qurate Agreements totaled $3.28 million and $9.06 million for the current six months and prior year six months, respectively, representing approximately 26% and 53% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year six months included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.
As of June 30, 2023 and December 31, 2022, the Company had receivables from Qurate of $1.6 million and $0.9 million, respectively, representing approximately 23% and 17% of the Company’s total net accounts receivable, respectively.

5. Accounts Receivable

Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances for credit losses. Such allowances were approximately $0.0 million as of both June 30, 2023 and December 31, 2022. The Company did not recognize any credit loss expense in the current quarter or current six months. There were no significant write-offs or recoveries in the current quarter or current six months.

Credit loss expense recognized in the prior year quarter and prior year six months was $0.09 million.

11

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

Also, as of June 30, 2023 and December 31, 2022, approximately $1.18 million and $1.65 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the third quarter of 2022, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During the current quarter and current six months, the Company paid approximately $0.02 million and $0.07 million in fees to the agent under the aforementioned services agreement.

6. Leases

The Company has an operating lease for its corporate offices and operations facility, as well as certain equipment with a term of 12 months or less.  As of June 30, 2023, the Company’s real estate lease has a remaining lease term of approximately 4.3 years, and the lease liability is measured using a discount rate of 6.25%.

Lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.4 million for both the current quarter and prior year quarter, approximately $0.8 million for the current six months, and approximately $0.7 million for the prior year six months.

Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter, approximately $0.8 million in the current six months, and approximately $1.0 million in the prior year six months.

Also, the Company was previously a party to an operating lease for its former retail store location, which was closed in 2022. During the three months ended June 30, 2023, the Company successfully negotiated a settlement with the lessor resulting in the termination of this lease. Under the settlement agreement, the Company paid $0.07 million to the lessor in May 2023, and agreed to make two subsequent payments of approximately $0.11 million each to the lessor on or before July 31, 2023 and October 31, 2023. The Company recognized a liability of $0.23 million for these remaining payments as part of “accounts payable, accrued expenses and other current liabilities” on the condensed consolidated balance sheet as of June 30, 2023. The Company recognized a gain of $0.44 million from this settlement transaction, which is classified within “other expense (income), including non-cash expenses” in the condensed consolidated statements of operations for the three and six months ended June 30, 2023.

12

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

As of June 30, 2023, the maturities of lease obligations were as follows:

($ in thousands)

    

2023 (July 1 through December 31)

$

776

2024

1,552

2025

 

1,552

2026

 

1,552

2027

 

1,294

Thereafter

 

-

Total lease payments

6,726

Less: Discount

847

Present value of lease liabilities

5,879

Current portion of lease liabilities

1,219

Non-current portion of lease liabilities

$

4,660

7. Debt

The Company did not have any debt obligations as of June 30, 2023 or December 31, 2022.

From December 30, 2021 through May 31, 2022, the Company had term loan debt outstanding pursuant to an agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”); this debt was repaid in full and extinguished on May 31, 2022. As a result of this extinguishment, the Company recognized a loss on early extinguishment of debt of approximately $2.3 million during the prior year quarter and prior year six months, consisting of approximately $1.4 million of debt prepayment premium, the immediate write-off of approximately $0.8 million of unamortized deferred finance costs, and approximately $0.1 million of other costs.

For the prior year quarter and prior year six months, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.48 million and $1.19 million, respectively, and the effective interest rate related to term loan debt was approximately 9.8%.

8. Stockholders’ Equity

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures

13

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized in the current quarter and prior year quarter for all forms of stock-based compensation was approximately $0.06 million and $0.58 million, respectively. Of the current quarter expense amount, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Of the prior year quarter expense amount, approximately $0.39 million related to employees and approximately $0.19 million related to directors and consultants. Approximately $0.48 million of the prior year quarter expense was recorded as operating costs, and approximately $0.10 million was recorded as a reduction to other income.

Total expense recognized in the current six months and prior year six months for all forms of stock-based compensation was approximately $0.12 million and $0.61 million, respectively. Of the current six months expense amount, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Of the prior year six months expense amount, approximately $0.40 million related to employees and approximately $0.21 million related to directors and consultants. Approximately $0.51 million of the prior year six months expense was recorded as operating costs, and approximately $0.10 million was recorded as a reduction to other income.

Stock Options

A summary of the Company’s stock options activity for the current six months is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

 

 

  

 

  

Exercised

 

(22,750)

 

1.00

 

  

 

  

Expired/Forfeited

 

(472,140)

 

3.84

 

  

 

  

Outstanding at June 30, 2023, and expected to vest

 

5,119,420

$

2.04

 

4.59

$

Exercisable at June 30, 2023

 

1,556,920

$

2.76

 

2.19

$

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.38 million, respectively. Compensation expense related to stock options for the current six months and the prior year six months was approximately $0.05 million and $0.40 million, respectively. Total unrecognized compensation expense related to unvested stock options at June 30, 2023 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.79 years.

14

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

A summary of the Company’s non-vested stock options activity for the current six months is as follows:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

 

Vested

 

(135,000)

0.68

Forfeited or Canceled

 

 

Balance at June 30, 2023

 

3,562,500

$

0.02

Warrants

A summary of the Company’s warrants activity for the current six months is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

1,000,000

 

1.50

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at June 30, 2023

 

1,116,065

$

1.67

 

8.97

$

88,009

Exercisable at June 30, 2023

 

116,065

$

3.15

 

1.09

$

On May 15, 2023, in connection with the Halston Master License (see Note 4), the Company issued to a licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied under the license agreement. The fair value of the warrants will be recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital.

No compensation expense related to warrants was recognized in the current quarter, prior year quarter, current six months, or prior year six months.

Stock Awards

A summary of the Company’s restricted stock activity for the current six months is as follows:  

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

66,668

 

0.67

Vested

 

(66,668)

 

0.67

Expired/Forfeited

 

 

Outstanding at June 30, 2023

 

333,333

$

3.71

15

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On April 17, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On May 15, 2023, the Company issued 50,000 shares of common stock to a consultant, which vested immediately.

Compensation expense related to stock awards was approximately $0.05 million for the current quarter and approximately $0.20 million for the prior year quarter. Compensation expense related to stock awards was approximately $0.08 million for the current six months and approximately $0.21 million for the prior year six months. Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2023 was approximately $0.03 million and is expected to be recognized over a weighted average period of approximately 0.79 years.

Restricted Stock Units

There were no restricted stock units outstanding as of June 30, 2023 and December 31, 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

As of June 30, 2023, there were 3,302,241 shares of common stock available for award grants under the 2021 Plan.

Shares Reserved for Issuance

As of June 30, 2023, there were 8,537,726 shares of common stock reserved for issuance, including 4,898,135 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 337,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,302,241 shares available for issuance under the 2021 Plan.

9.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

16

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

The following table is a reconciliation of the numerator and denominator of the basic and diluted net (loss) income per share computations for the three and six months ended June 30, 2023 and 2022:

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Numerator:

Net (loss) income attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(3,468)

$

9,490

$

(9,111)

$

6,003

Denominator:

Basic weighted average number of shares outstanding

 

19,735,500

 

19,677,243

19,684,630

 

19,624,474

 

Add: Effect of warrants

 

 

657

 

639

 

Add: Effect of stock options

136,548

131,662

Diluted weighted average number of shares outstanding

 

19,735,500

 

19,814,448

19,684,630

 

19,756,775

Basic net loss per share

$

(0.18)

$

0.48

$

(0.46)

$

0.31

Diluted net loss per share

$

(0.18)

$

0.48

$

(0.46)

$

0.30

As a result of the net loss for the current quarter and current six months, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

 

Three Months Ended

Six Months Ended

 

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Stock options

5,119,420

5,781,890

5,119,420

5,781,890

Warrants

1,116,065

116,065

1,116,065

116,065

Total

6,235,485

 

5,897,955

6,235,485

 

5,897,955

 

10.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% and 25%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively.

For the current quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 10%, partially offset by the reversal of a valuation allowance that was previously recorded in the first quarter of 2022, which decreased the effective tax rate by approximately 6%.

17

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

The estimated annual effective income tax rate for the current six months and the prior year six months was approximately 0% and 35%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively.

For the current six months, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 14%.

11.    Related Party Transactions

IM Topco, LLC

The Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. For the three and six months ended June 30, 2023, the Company recognized service fee income related to this agreement of $75,000 and $150,000, respectively.

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed royalties to IM Topco of $400,000 per year. Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three and six months ended June 30, 2023, the estimated amount of such shortfall was approximately $60,000 and $120,000, respectively, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

12.    Commitments and Contingencies

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in Accounting Standards Codification Subtopic 805-50. Based on the performance of the Lori Goldstein brand through December 31, 2022, approximately $0.2 million of additional consideration has been earned by the seller to date, and this amount was paid to the seller in the current six months. At December 31, 2022, $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a

18

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2023

(Unaudited)

long-term liability. At June 30, 2023, $1.4 million of the remaining balance was recorded as a current liability and $5.0 million was recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 2), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP will be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation, and management believes the likelihood of any such payment is remote. Based on IM Topco’s earnings from May 31, 2022 through June 30, 2023 and the applicable distribution provisions, WHP earned $7.9 million in cash flow, which reduces the maximum potential purchase price adjustment to $8.1 million.

Legal Proceedings

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

19

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Factors section of our Form 10-K for the fiscal year ended December 31, 2022, as filed with the SEC on April 17, 2023. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as one thing. Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
We manage the Longaberger Brand through our 50% ownership interest in Longaberger Licensing, LLC.
We manage the Q Optix business through our 50% ownership interest in Q Optix, LLC.
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, we sold a majority interest in the brand to a third party, but retained a 30% noncontrolling interest in the brand and continue to contribute to the operations of the brand through a service agreement.

Xcel continues to pioneer a true omni-channel sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, wholesale, and e-commerce channels to be everywhere its customers shop. Our brands have generated over $3 billion in retail sales via live streaming in interactive television and digital channels alone

Our objective is to build a diversified portfolio of lifestyle consumer brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

distribution and/or licensing of our brands for sale through interactive television (i.e., QVC, HSN, The Shopping Channel, TVSN, CJO, JTV, etc.);
licensing of our brands to retailers that sell to the end consumer;
direct-to-consumer distribution of our brands through e-commerce and live streaming;
licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels whereby we provide certain design services; and

20

acquiring additional consumer brands and integrating them into our operating platform and leveraging our operating infrastructure and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

our management team, including our officers’ and directors’ experience in, and relationships within the industry;
our deep knowledge, expertise, and proprietary technology in live streaming;
our design, production, sales, marketing, and supply chain and integrated technology platform that enables us to design and distribute trend-right product; and
our significant media and internet presence.

We utilize state-of-the-art supply chain management technology, trend analytics, and data science to actively monitor fashion trends and read and react to customer demands.

Summary of Operating Results

Three months ended June 30, 2023 (the “current quarter”) compared with the three months ended June 30, 2022 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased approximately $1.7 million to $6.8 million from $8.5 million for the prior year quarter.

Net licensing revenue decreased by approximately $2.8 million in the current quarter to $2.4 million, compared with $5.2 million in the prior year quarter. This decrease in licensing revenue was primarily attributable to the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand through the sale of a 70% interest in IM Topco, LLC to WHP. Since the closing of such sale, we no longer record Isaac Mizrahi brand licensing revenue as part of our revenues.

Net sales increased by approximately $1.1 million in the current quarter to $4.4 million, compared with $3.3 million in the prior year quarter. This increase was primarily attributable to the sale of all of our Judith Ripka fine jewelry inventory to JTV as part of the restructuring and transformation of our business operating model, which has been substantially completed as of June 30, 2023.

Cost of Goods Sold

Current quarter cost of goods sold was $3.8 million, compared with $2.6 million for the prior year quarter.

Gross profit margin from net product sales (net sales less cost of goods sold, divided by net sales) decreased from approximately 22% in the prior year quarter to approximately 13% in the current quarter. The decrease in gross profit margin percentage was the result of selling all remaining jewelry at an agreed-upon price which was less than historical margins and the sale of the remaining apparel inventory at discounted sales amounts.

Gross profit (net revenue less cost of goods sold) decreased approximately $2.9 million to $3.0 million from $5.9 million in the prior year quarter, primarily driven by the aforementioned decrease in net licensing revenue.

21

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $4.3 million from $9.5 million in the prior year quarter to $5.2 million in the current quarter. This decrease was primarily attributable to lower salaries, benefits and employment costs, driven by the combination of (i) the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand and the transfer of the employees associated with the Isaac Mizrahi brand to the IM Topco, LLC business venture, and (ii) reductions in staffing levels during the current quarter related to the restructuring and transformation of our business operating model. These decreases were partially offset by a $0.1 million impairment charge related to certain capitalized software assets.

Other Operating Costs and Expenses (Income)

In the prior year quarter, we recognized a gain on the sale of a majority interest in the Isaac Mizrahi brand of approximately $20.6 million, which was comprised of $46.2 million of cash proceeds plus the recognition of the fair value of our retained interest in the brand of $19.8 million, less $0.9 million of fees and expenses directly related to the transaction and the derecognition of the brand trademarks previously recorded on our balance sheet of $44.5 million.

We account for our interest in the ongoing operations of IM Topco, LLC using the equity method of accounting. We recognized an equity method loss of $0.52 million related to our investment for the current quarter, based on the distribution provisions set forth in the related business venture agreement.

Also during the current quarter, we recognized a gain of $0.35 million related to the sale of a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016, and a gain of $0.44 million related to a lease termination settlement with the landlord of our former retail store location.

Depreciation and amortization was approximately $1.8 million in both the current quarter and prior year quarter.

Interest and Finance Expense

Interest and finance expense for the current quarter was $0.0 million, compared with $2.8 million for the prior year quarter. This decrease was attributable to the May 31, 2022 repayment of all of our outstanding term loan debt, which resulted in a $2.3 million loss on early extinguishment of debt in the prior year quarter.

Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% and 25%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively.

For the current quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 10%, partially offset by the reversal of a valuation allowance that was previously recorded in the first quarter of 2022, which decreased the effective tax rate by approximately 6%.

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $3.5 million for the current quarter, compared with net income of $9.5 million for the prior year quarter, due to the combination of the factors outlined above.

22

Non-GAAP Net (Loss) Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $1.7 million, or $0.09 per diluted share (“non-GAAP diluted EPS”), for the current quarter and a non-GAAP net loss of $3.6 million, or $0.18 per diluted share, for the prior year quarter. Non-GAAP net (loss) income is a non-GAAP unaudited term, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders, exclusive of amortization of trademarks, our proportional share of trademark amortization of equity method investees, stock-based compensation, loss on extinguishment of debt, gain on sale of assets, gain on lease termination, asset impairments, and income taxes. Non-GAAP net income and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(0.9) million for the current quarter, compared with approximately $(2.8) million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders before depreciation and amortization, our proportional share of trademark amortization of equity method investees, interest and finance expenses (including loss on extinguishment of debt, if any), income taxes, other state and local franchise taxes, stock-based compensation, gain on sale of assets, gain on lease termination, asset impairments, and operating losses stemming from certain of our businesses that have been restructured or discontinued.

Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any other unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

23

The following table is a reconciliation of net (loss) income attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net (loss) income:

 

Three Months Ended

June 30, 

($ in thousands)

    

2023

    

2022

Net (loss) income attributable to Xcel Brands, Inc. stockholders

$

(3,468)

$

9,490

Amortization of trademarks

 

1,525

 

1,525

Proportional share of trademark amortization of equity method investee

515

Stock-based compensation

 

65

 

485

Loss on extinguishment of debt

2,324

Gain on sale of assets

(20,608)

Gain on lease termination

(445)

Asset impairment

100

Income tax provision

 

 

3,178

Non-GAAP net loss

$

(1,708)

$

(3,606)

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

Three Months Ended

June 30, 

    

2023

    

2022

Diluted (loss) earnings per share

$

(0.18)

$

0.48

Amortization of trademarks

 

0.08

 

0.08

Proportional share of trademark amortization of equity method investee

0.03

Stock-based compensation

 

0.00

 

0.03

Loss on extinguishment of debt

0.12

Gain on sale of assets

(1.05)

Gain on lease termination

(0.02)

Asset impairment

0.00

Income tax provision

 

 

0.16

Non-GAAP diluted EPS

$

(0.09)

$

(0.18)

Non-GAAP weighted average diluted shares

 

19,735,500

 

19,677,243

The following table is a reconciliation of net (loss) income attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

Three Months Ended

June 30, 

($ in thousands)

    

2023

    

2022

Net (loss) income attributable to Xcel Brands, Inc. stockholders

$

(3,468)

$

9,490

Depreciation and amortization

 

1,786

 

1,812

Proportional share of trademark amortization of equity method investee

515

Interest and finance (income) expense

 

(7)

 

2,802

Income tax provision

 

 

3,178

State and local franchise taxes

 

23

 

Stock-based compensation

 

65

 

485

Gain on sale of assets

(20,608)

Gain on lease termination

(445)

Asset impairment

100

Losses from discontinued businesses

495

Adjusted EBITDA

$

(936)

$

(2,841)

24

Six months ended June 30, 2023 (the “current six months”) compared with the six months ended June 30, 2022 (the “prior year six months”)

Revenues

Current six months net revenue decreased approximately $4.4 million to $12.8 million from $17.2 million for the prior year six months.

Net licensing revenue decreased by approximately $6.4 million in the current six months to $4.7 million, compared with $11.1 million in the prior year six months. This decrease in licensing revenue was primarily attributable to the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand through the sale of a 70% interest in IM Topco, LLC to WHP. Since the closing of such sale, we no longer record Isaac Mizrahi brand licensing revenue as part of our revenues.

Net sales increased by approximately $2.1 million in the current six months to $8.2 million, compared with $6.1 million in the prior year six months. This increase was primarily attributable to sale of all of our C Wonder apparel inventory to HSN and the sale of all of our Judith Ripka fine jewelry inventory to JTV, as part of the restructuring and transformation of our business operating model, which has been substantially completed as of June 30, 2023.

Cost of Goods Sold

Current six months cost of goods sold was $6.5 million, compared with $4.3 million for the prior year six months.

Gross profit margin from net product sales (net sales less cost of goods sold, divided by net sales) decreased from approximately 30% in the prior year six months to approximately 21% in the current six months. The decrease in gross profit margin percentage was the result of selling all remaining jewelry at an agreed-upon price which was less than historical margins and the sale of the remaining apparel inventory at discounted sales amounts.

Gross profit (net revenue less cost of goods sold) decreased approximately $6.6 million to $6.3 million from $12.9 million in the prior year six months, primarily driven by the aforementioned decrease in net licensing revenue.

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $5.7 million from $17.8 million in the prior year six months to $12.1 million in the current six months. This decrease was primarily attributable to lower salaries, benefits and employment costs, driven by the combination of (i) the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand and the transfer of the employees associated with the Isaac Mizrahi brand to the IM Topco, LLC business venture, and (ii) reductions in staffing levels and other costs during the current six months related to the restructuring and transformation of our business operating model. These decreases were partially offset by a $0.1 million impairment charge related to certain capitalized software assets.

Other Operating Costs and Expenses (Income)

In the prior year six months, we recognized a gain on the sale of a majority interest in the Isaac Mizrahi brand of approximately $20.6 million, which was comprised of $46.2 million of cash proceeds plus the recognition of the fair value of our retained interest in the brand of $19.8 million, less $0.9 million of fees and expenses directly related to the transaction and the derecognition of the brand trademarks previously recorded on our balance sheet of $44.5 million.

We account for our interest in the ongoing operations of IM Topco, LLC using the equity method of accounting. We recognized an equity method loss of $1.03 million related to our investment for the current six months, based on the distribution provisions set forth in the related business venture agreement.

Also during the current six months, we recognized a gain of $0.35 million related to the sale of a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016, and a gain of $0.44 million related to a lease termination settlement with the landlord of our former retail store location.

25

Depreciation and amortization was approximately $3.6 million in both the current six months and prior year six months.

Interest and Finance Expense

Interest and finance expense for the current six months was $0.0 million, compared with $3.5 million for the prior year six months. This decrease was attributable to the May 31, 2022 repayment of all of our outstanding term loan debt, which resulted in a $2.3 million loss on early extinguishment of debt in the prior year six months.

Income Taxes

The estimated annual effective income tax rate for the current six months and the prior year six months was approximately 0% and 35%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively.

For the current six months, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 14%.

Net (Loss) Income Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $9.1 million for the current six months, compared with net income of $6.0 million for the prior year six months, due to the combination of the factors outlined above.

Non-GAAP Net (Loss) Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $5.3 million, or $0.27 per diluted share for the current six months and a non-GAAP net loss of $5.5 million, or $0.28 per diluted share, for the prior year six months.

We had Adjusted EBITDA of approximately $(2.9) million for the current six months, compared with approximately $(3.7) million for the prior year six months.

The following table is a reconciliation of net (loss) income attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net (loss) income:

 

Six Months Ended

June 30, 

($ in thousands)

    

2023

    

2022

Net (loss) income attributable to Xcel Brands, Inc. stockholders

$

(9,111)

$

6,003

Amortization of trademarks

 

3,045

 

3,039

Proportional share of trademark amortization of equity method investee

1,030

Stock-based compensation

 

122

 

517

Loss on extinguishment of debt

2,324

(Recovery of) costs in connection with potential acquisition

Gain on sale of assets

(20,608)

Gain on lease termination

(445)

Asset impairment

100

Income tax provision

 

 

3,178

Non-GAAP net loss

$

(5,259)

$

(5,547)

26

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

Six Months Ended

June 30, 

    

2023

    

2022

Diluted (loss) earnings per share

$

(0.46)

$

0.30

Amortization of trademarks

 

0.15

 

0.16

Proportional share of trademark amortization of equity method investee

0.05

Stock-based compensation

 

0.01

 

0.03

Loss on extinguishment of debt

0.12

Gain on sale of assets

(1.05)

Gain on lease termination

(0.02)

Asset impairment

0.00

Income tax provision

 

 

0.16

Non-GAAP diluted EPS

$

(0.27)

$

(0.28)

Non-GAAP weighted average diluted shares

 

19,684,630

 

19,624,474

The following table is a reconciliation of net (loss) income attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

Six Months Ended

June 30, 

($ in thousands)

    

2023

    

2022

Net (loss) income attributable to Xcel Brands, Inc. stockholders

$

(9,111)

$

6,003

Depreciation and amortization

 

3,583

 

3,632

Proportional share of trademark amortization of equity method investee

1,030

Interest and finance expense

 

18

 

3,511

Income tax provision

 

 

3,178

State and local franchise taxes

 

44

 

36

Stock-based compensation

 

122

 

517

Gain on sale of assets

(20,608)

Gain on lease termination

(445)

Asset impairment

100

Losses from discontinued businesses

1,728

Adjusted EBITDA

$

(2,931)

$

(3,731)

Liquidity and Capital Resources

General

As of June 30, 2023 and December 31, 2022, our cash and cash equivalents were $3.5 million and $4.6 million, respectively.

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. Notwithstanding our recent investments in our ERP system and our brick-and-mortal retail store in 2020 and 2021, respectively, our business operating model generally does not require material capital expenditures, and as of June 30, 2023, we have no significant commitments for future capital expenditures.

Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of operating lease obligations and any contingent obligations payable in common stock) was $6.0 million and $8.8 million as of June 30, 2023 and December 31, 2022, respectively.

27

Liquidity and Management’s Plans  

We incurred a net loss attributable to Company stockholders of approximately $3.5 million and $9.1 million during the three and six months ended June 30, 2023, respectively (which included net non-cash expenses of approximately $1.7 million and $4.0 million, respectively), and had an accumulated deficit of approximately $41.9 million as of June 30, 2023. Net cash used in operating activities was approximately $1.5 million for the six months ended June 30, 2023. These factors, along with our current levels of cash and working capital, raise uncertainties about the Company’s ability to continue as a going concern.

Management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, we began to restructure our business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. We entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, we licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes other new celebrity brands that we plan to develop and launch in 2023 and beyond. For the Halston Brand, on May 15, 2023, we entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers. This new master license for the Halston Brand provides for an upfront cash payment and royalties to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

The transition of these operating businesses was substantially completed as of June 30, 2023. We believe that this evolution of our operating model will provide significant cost savings and allow us to reduce and better manage our exposure to operating risks. As of June 30, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses by approximately $7 million, on an annualized basis when compared to the corresponding periods in the prior year.

Based on these recent events and changes in our business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of June 30, 2023, have been alleviated.

Commentary on the components of our cash flows for the current quarter as compared with the prior year quarter is set forth below.

Operating Activities

Net cash used in operating activities was approximately $1.47 million in the current six months, compared with approximately $8.72 million in the prior year six months.

The current six months cash used in operating activities was primarily attributable to the combination of the net loss of $(9.64) million plus non-cash items of approximately $4.04 million and the net change in operating assets and liabilities of approximately $4.13 million. Non-cash items were primarily comprised of $3.58 million of depreciation and amortization and the $1.03 million undistributed proportional share of net loss of equity method investee, partially offset by a $(0.35) gain on the sale of a financial asset and a $(0.44) gain on the settlement of a lease liability. The net change in operating assets and liabilities was primarily comprised of (i) an increase in deferred revenue of approximately $5.04 million, which was mainly attributable to the upfront payment received for the Halston Master License agreement entered into during the current six months, (ii) a decrease in inventory of approximately $2.05 million, driven by the sale of all of our C Wonder apparel inventory to HSN and the sale of all of our Judith Ripka fine jewelry inventory to JTV, as part of the restructuring and transformation of our business operating model. Partially offsetting these net changes in operating

28

assets and liabilities were increases in accounts receivable of approximately $(1.77) million and deceases in various operating liabilities of approximately $(1.64) million.

The prior year six months cash used in operating activities was primarily attributable to the combination of the net income of $5.45 million plus non-cash items of approximately $(12.51) million and the net change in operating assets and liabilities of approximately $(1.66) million. Non-cash items were primarily comprised of a $(20.61) million net gain on the sale of the assets of the Isaac Mizrahi brand, $3.63 million of depreciation and amortization, $0.52 million of stock-based compensation, a $2.32 million loss on extinguishment of debt, and $1.38 million of deferred taxes. The net change in operating assets and liabilities was primarily comprised of an increase in accounts receivable of $(1.74) million, an increase in accounts payable, accrued expenses, and other liabilities of $0.55 million, a decrease in other liabilities of $(0.22) million, and changes in lease-related assets and liabilities of $(0.16) million.

Investing Activities

Net cash provided by investing activities for the current six months was approximately $0.37 million, primarily driven by $0.45 million of proceeds received from the sale of a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016.

Net cash provided by investing activities for the prior year six months was approximately $45.32 million, and was almost entirely attributable to $45.41 million of net proceeds from the sale of a majority interest in the Isaac Mizrahi brand to WHP.  

Financing Activities

Net cash used in financing activities for the prior year six months was approximately $30.95 million, which mainly consisted of $29.00 million of repayments of our term loan debt, and, to a lesser extent, $1.51 million of prepayment and other fees associated with the extinguishment of debt, as well as $0.44 million of shares repurchased related to withholding taxes on vested restricted stock.  

There was no cash used in or provided by financing activities in the current six months.

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Lori Goldstein brand, Halston brand, and C Wonder brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

While the recent sale of a majority interest in the Isaac Mizrahi brand has resulted in a short-term decrease in our revenues, as that brand represented a significant portion of our historical revenues, we are taking actions to replace those revenues in the long-term with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, additional domestic and international licensing arrangements, and acquiring additional brands, including recent launches of our Victor Glemaud and C Wonder by Christian Siriano businesses on HSN.

In the first quarter of 2023, we began to restructure our business operations by shifting our business from a wholesale/licensing hybrid model into a “licensing-plus” business model. These efforts included entering into new structured contractual arrangements with best-in-class business partners in order to more efficiently operate our wholesale and e-commerce businesses and reduce and better manage our exposure to operating risks. These restructuring initiatives have been substantially completed as of June 30, 2023.

29

However, we continue to face a number of headwinds in the current macroeconomic environment. The global shipping industry has experienced and continues to experience challenges related to port delays and reduced availability for carriers and containers. This situation has negatively impacted our supply chain partners, including third party manufacturers, logistics providers, and other vendors, as well as the supply chains of our licensees, and has resulted in increased cost of supply and freight costs for us and our licensees. Such higher costs are currently expected to continue for at least the majority of 2023.  

Further, the cost of raw materials, labor, manufacturing, energy, fuel, shipping and logistics, and other inputs related to the production and distribution of our products have increased and may continue to increase unexpectedly. Beginning in the first quarter of 2022, input costs increased significantly. We expect the pressures of input cost inflation to continue for at least the majority of 2023. We may not be able to mitigate the impact of inflation and cost increases or pass these costs along to our customers.

Also, poor economic and market conditions, including a potential recession, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of inflation as well as a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and continue to attract wholesale and direct-to-consumer customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, changes in the prices of supplies, consolidation of retail establishments, and other factors noted in Item 1A of our most recent Annual Report on Form 10-K could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on April 17, 2023, for a discussion of our critical accounting policies and estimates.

Effective January 1, 2023, we adopted the provisions of Accounting Standards Update No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended). Although

30

the adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition, it represented a change in our accounting policy with respect to the estimation of allowance for uncollectible accounts. Refer to Part I, Item 1, Note 5 of this Quarterly Report on Form 10-Q for additional information. During the three and six months ended June 30, 2023, there were no other material changes to our accounting policies.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4.    CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 30, 2023, the end of the period covered by this report. Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of June 30, 2023 such that the information required to be disclosed in our SEC reports is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

In the ordinary course of business, from time to time we become involved in legal claims and litigation. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against us is unlikely to have, individually or in the aggregate, a materially adverse effect on our business, financial position, or results of operations.

ITEM 1A.    RISK FACTORS

We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no sales of unregistered or registered securities during the three months ended June 30, 2023.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

31

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

The following exhibits are filed herewith:

31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)

31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)

32.1 Section 1350 Certification (CEO) *

32.2 Section 1350 Certification (CFO) *

101.INS Inline XBRL Instance Document

101.SCH Inline XBRL Taxonomy Extension Schema Document

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 14, 2023

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer

 

 

 

 

By:

/s/ James Haran

 

 

Name: James Haran

 

 

Title: Chief Financial Officer and Vice President

32

EX-31.1 2 xelb-20230630xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert W. D’Loren, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 14, 2023

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer


EX-31.2 3 xelb-20230630xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Haran, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 14, 2023

By:

/s/ James Haran

 

 

Name: James Haran

Title: Chief Financial Officer and Vice President

 

 


EX-32.1 4 xelb-20230630xex32d1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert W. D’Loren, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 14, 2023

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer


EX-32.2 5 xelb-20230630xex32d2.htm EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James Haran, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 14, 2023

By:

/s/ James Haran

 

 

Name: James Haran

 

 

Title: Chief Financial Officer and Vice President


EX-101.SCH 6 xelb-20230630.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Leases - Maturities of Lease Liabilities (Details) (Calc2) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Equity Method Investment - IM Topco, LLC (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Equity Method Investment - Summarized financial information (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Signifcant Contracts and Concentrations - Halson Master License (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Significant Contracts and Concentrations - Qurate Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Stockholders' Equity - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 40805 - Disclosure - Stockholders' Equity - Outstanding and vesting options (Details) link:presentationLink link:calculationLink link:definitionLink 40806 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) link:presentationLink link:calculationLink link:definitionLink 40807 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40808 - Disclosure - Stockholders' Equity - Stock Awards (Details) link:presentationLink link:calculationLink link:definitionLink 40809 - Disclosure - Stockholders' Equity - Restricted Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Subsequent Events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9940202 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable 10K (Details) link:presentationLink link:calculationLink link:definitionLink 9940204 - Disclosure - Summary of Significant Accounting Policies - Trademarks and Other Intangible Assets 10K (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Equity Method Investment link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Trademarks and Other Intangibles link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Significant Contracts link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Equity Method Investment (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Trademarks and Other Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 xelb-20230630_cal.xml EX-101.CAL EX-101.DEF 8 xelb-20230630_def.xml EX-101.DEF EX-101.LAB 9 xelb-20230630_lab.xml EX-101.LAB EX-101.PRE 10 xelb-20230630_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2023
Aug. 09, 2023
Document And Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Current Fiscal Year End Date --12-31  
Document Transition Report false  
Entity File Number 001-37527  
Entity Registrant Name XCEL BRANDS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 76-0307819  
Entity Address, Address Line One 1333 Broadway, 10th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10018  
City Area Code 347  
Local Phone Number 727-2474  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol XELB  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   19,707,956
Entity Central Index Key 0001083220  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 3,507 $ 4,608
Accounts receivable, net 6,878 5,110
Inventory 798 2,845
Prepaid expenses and other current assets 554 1,457
Total current assets 11,737 14,020
Non-current Assets:    
Property and equipment, net 916 1,418
Operating lease right-of-use assets 4,946 5,420
Trademarks and other intangibles, net 44,590 47,665
Equity method investment 18,165 19,195
Deferred tax assets, net 1,107 1,107
Other assets 25 110
Total non-current assets 69,749 74,915
Total Assets 81,486 88,935
Current Liabilities:    
Accounts payable, accrued expenses and other current liabilities 2,750 3,870
Deferred revenue 922 88
Accrued income taxes payable 555 568
Accrued payroll 154 416
Current portion of operating lease obligations 1,219 1,376
Current portion of contingent obligations 1,400 243
Total current liabilities 7,000 6,561
Long-Term Liabilities:    
Long-term portion of operating lease obligations 4,660 5,839
Deferred revenue 4,207  
Long-term portion of contingent obligations 4,996 6,396
Total long-term liabilities 13,863 12,235
Total Liabilities 20,863 18,796
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value, 50,000,000 shares authorized, and 19,633,194 and 19,624,860 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 20 20
Paid-in capital 103,715 103,592
Accumulated deficit (41,908) (32,797)
Total Xcel Brands, Inc. stockholders' equity 61,827 70,815
Noncontrolling interest (1,204) (676)
Total Stockholders' Equity 60,623 70,139
Total Liabilities and Stockholders' Equity $ 81,486 $ 88,935
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 19,700,656 19,624,860
Common stock, shares outstanding (in shares) 19,700,656 19,624,860
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues        
Net revenue $ 6,781 $ 8,467 $ 12,831 $ 17,214
Cost of goods sold 3,800 2,570 6,493 4,250
Gross profit 2,981 5,897 6,338 12,964
Direct operating costs and expenses        
Salaries, benefits and employment taxes 2,241 5,236 5,706 10,089
Other selling, general and administrative expenses 2,943 4,288 6,436 7,712
Total direct operating costs and expenses 5,184 9,524 12,142 17,801
Operating loss before other operating costs and expenses (income) (2,203) (3,627) (5,804) (4,837)
Other operating costs and expenses (income)        
Depreciation and amortization expense 1,786 1,812 3,583 3,632
Gain on sale of majority interest in Isaac Mizrahi brand   (20,608)   (20,608)
Loss from equity method investment 515   1,030  
Gain on sale of limited partner ownership interest (351)   (351)  
Gain on settlement of lease liability (445)   (445)  
Operating loss (3,708) 15,169 (9,621) 12,139
Interest and finance (income) expense        
Interest expense - term loan debt   479   1,187
Other interest and finance charges, net (7) (1) 18  
Loss on early extinguishment of debt   2,324   2,324
Total interest and finance (income) expense (7) 2,802 18 3,511
Loss before income taxes (3,701) 12,367 (9,639) 8,628
Income tax (benefit) provision 0 3,178 0 3,178
Net (loss) income (3,701) 9,189 (9,639) 5,450
Net loss attributable to noncontrolling interest (233) (301) (528) (553)
Net (loss) income attributable to Xcel Brands, Inc. stockholders $ (3,468) $ 9,490 $ (9,111) $ 6,003
(Loss) earnings per common share attributable to Xcel Brands, Inc. stockholders:        
Basic net (loss) income per share $ (0.18) $ 0.48 $ (0.46) $ 0.31
Diluted net (loss) income per share $ (0.18) $ 0.48 $ (0.46) $ 0.30
Weighted average number of common shares outstanding:        
Basic weighted average number of shares outstanding 19,735,500 19,677,243 19,684,630 19,624,474
Diluted weighted average common shares outstanding 19,735,500 19,814,448 19,684,630 19,756,775
Net licensing revenue        
Revenues        
Net revenue $ 2,428 $ 5,175 $ 4,650 $ 11,136
Net sales        
Revenues        
Net revenue $ 4,353 $ 3,292 $ 8,181 $ 6,078
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Employees
Common Stock
Executive Officer [Member]
Common Stock
Consultants
Common Stock
Director
Common Stock
Paid-In Capital [Member]
Employees
Paid-In Capital [Member]
Executive Officer [Member]
Paid-In Capital [Member]
Consultants
Paid-In Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Member]
Employees
Executive Officer [Member]
Consultants
Total
Balances at Dec. 31, 2021         $ 20       $ 103,039 $ (28,779) $ 662       $ 74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 30           30
Net income (loss)                   (3,487) (252)       (3,739)
Balances at Mar. 31, 2022         $ 20       103,069 (32,266) 410       71,233
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Balances at Dec. 31, 2021         $ 20       103,039 (28,779) 662       74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             5,450
Balances at Jun. 30, 2022         $ 20       103,490 (22,776) 109       80,843
Balances (in shares) at Jun. 30, 2022         19,624,860                    
Balances at Mar. 31, 2022         $ 20       103,069 (32,266) 410       71,233
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 402           402
Shares issued related to/in connection with stock grant           $ 50 $ 281 $ 33       $ 50 $ 281 $ 33  
Shares issued related to/in connection with stock grant 33,557 178,727 20,064 50,000                      
Shares issued to consultant in connection with Isaac Mizrahi sale transaction                 97           97
Shares issued to consultant in connection with Isaac Mizrahi sale transaction         65,275                    
Shares repurchased in exchange for withholding taxes           $ (357) $ (85)         $ (357) $ (85)    
Shares repurchased in exchange for withholding taxes (in shares) (240,000) (53,882)                          
Net income (loss)                   9,490 (301)       9,189
Balances at Jun. 30, 2022         $ 20       103,490 (22,776) 109       80,843
Balances (in shares) at Jun. 30, 2022         19,624,860                    
Balances at Dec. 31, 2022         $ 20       103,592 (32,797) (676)       70,139
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 51           51
Shares issued to consultant in connection with stock grant                 6           6
Shares issued to consultant in connection with stock grant (in shares)         8,334                    
Net income (loss)                   (5,643) (295)       (5,938)
Balances at Mar. 31, 2023         $ 20       103,649 (38,440) (971)       64,258
Balances (in shares) at Mar. 31, 2023         19,633,194                    
Balances at Dec. 31, 2022         $ 20       103,592 (32,797) (676)       70,139
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             (9,639)
Balances at Jun. 30, 2023         $ 20       103,715 (41,908) (1,204)       60,623
Balances (in shares) at Jun. 30, 2023         19,700,656                    
Balances at Mar. 31, 2023         $ 20       103,649 (38,440) (971)       64,258
Balances (in shares) at Mar. 31, 2023         19,633,194                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 27           27
Shares issued to consultant in connection with stock grant                 39           39
Shares issued to consultant in connection with stock grant (in shares)         58,334                    
Shares issued on exercise of stock options, net (in shares)         9,128                    
Net income (loss)                   (3,468) (233)       (3,701)
Balances at Jun. 30, 2023         $ 20       $ 103,715 $ (41,908) $ (1,204)       $ 60,623
Balances (in shares) at Jun. 30, 2023         19,700,656                    
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities        
Net income (loss) $ (3,701) $ 9,189 $ (9,639) $ 5,450
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization expense 1,786 1,812 3,583 3,632
Asset impairment charges     100  
Amortization of deferred finance costs included in interest expense       156
Stock-based compensation     122 517
Provision for doubtful accounts       90
Undistributed proportional share of net loss of equity method investee     1,030  
Loss on early extinguishment of debt   2,324   2,324
Deferred income tax (benefit) provision       1,384
Gain on sale of majority interest in Isaac Mizrahi brand   (20,608)   (20,608)
Gain on sale of limited partner ownership interest (351)   (351)  
Gain on settlement of lease liability (445)   (445)  
Changes in operating assets and liabilities:        
Accounts receivable     (1,768) (1,741)
Inventory     2,047 (100)
Prepaid expenses and other current and non-current assets     863 8
Deferred revenue     5,041 347
Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities     (1,637) 205
Lease-related assets and liabilities     (417) (159)
Other liabilities       (224)
Net cash used in operating activities     (1,471) (8,719)
Cash flows from investing activities        
Net proceeds from sale of majority interest in Isaac Mizrahi brand       45,408
Net proceeds from sale of assets     451  
Purchase of property and equipment     (81) (85)
Net cash provided by (used in) investing activities     370 45,323
Cash flows from financing activities        
Shares repurchased including vested restricted stock in exchange for withholding taxes       (442)
Payment of long-term debt       (29,000)
Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt       (1,511)
Net cash (used in) provided by financing activities       (30,953)
Net (decrease) increase in cash and cash equivalents     (1,101) 5,651
Cash and cash equivalents at beginning of period     4,608 5,222
Cash and cash equivalents at end of period 3,507 10,873 3,507 10,873
Reconciliation to amounts on consolidated balance sheets:        
Cash and cash equivalents 3,507   3,507  
Total cash, cash equivalents, and restricted cash $ 3,507 $ 10,873 3,507 10,873
Supplemental disclosure of cash flow information:        
Cash paid during the period for interest       $ 1,032
Cash paid during the period for income taxes     $ 16  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations, Background, and Basis of Presentation
6 Months Ended
Jun. 30, 2023
Nature of Operations, Background, and Basis of Presentation [Abstract]  
Nature of Operations, Background, and Basis of Presentation

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2022 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023.

The Company is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company manages the Q Optix business through its 50% ownership interest in Q Optix, LLC; the Company consolidates Q Optix, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a 30% ownership interest in IM Topco, LLC, and continues to contribute to the operations of the brand through a service agreement (see Note 11 for additional details). The Company accounts for its interest in IM Topco, LLC using the equity method of accounting.

The Company designs, produces, markets, and distributes products, licenses its brands to third parties, and generates licensing revenues through contractual arrangements with manufacturers and retailers. The Company and its licensees distribute through an omni-channel retail sales strategy, which includes distribution through interactive television, digital live-stream shopping, wholesale, and e-commerce channels to be everywhere its customers shop.

The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Condensed Consolidated Statements of Operations, separately from the Company’s net licensing revenue.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $3.5 million and $9.1 million during the three and six months ended June 30, 2023, respectively (which included net non-cash expenses of approximately $1.7 million and $4.0 million, respectively), and had an accumulated deficit of approximately $41.9 million as of June 30, 2023. Net cash used in operating activities was approximately $1.5 million for the six months ended June 30, 2023. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent obligations payable in common stock) of approximately $6.0 million as of June 30, 2023. The Company’s cash and cash equivalents were approximately $3.5 million as of June 30, 2023. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

Management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2023 and beyond. For the Halston Brand, on May 15, 2023, the Company entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 4). This new master license for the Halston Brand provides for an upfront cash payment and royalties, including certain guaranteed minimum royalties to the Company, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

The transition of these operating businesses was substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of June 30, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses by approximately $7 million, on an annualized basis when compared to the corresponding periods in the prior year.

Based on these recent events and changes in the Company’s business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of June 30, 2023, have been alleviated.

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Method Investment
3 Months Ended
Mar. 31, 2023
Equity Method Investment, Summarized Financial Information [Abstract]  
Equity Method Investment

2.      Equity Method Investment

IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

The purchase price paid by WHP to the Company at the closing of the transaction consisted of $46.2 million in cash. The Company incurred approximately $0.9 million of expenses directly related to this transaction, including legal fees and agent fees, of which $0.1 million of the agent fees were paid through the issuance of 65,275 shares of the Company’s common stock, which were recognized as a reduction to the gain from the transaction. The Company recognized a net pre-tax gain from the transaction of $20.6 million, which is classified within “other expense (income), including non-cash expenses” in the condensed consolidated statements of operations for the three and six months ended June 30, 2022.

The Company accounts for its 30% interest in the ongoing operations of IM Topco as other expense (income) under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective percentage interests.

Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million and $1.03 million related to its investment for the three and six months ended June 30, 2023, respectively. The Company did not recognize any equity income or loss related to its investment for the three and six months ended June 30, 2022.

Summarized financial information for IM Topco for the three and six months ended June 30, 2023 is as follows:

    

For the three

    

For the six

months ended

months ended

June 30,

June 30,

($ in thousands)

2023

2023

Revenues

$

3,573

$

6,919

Gross profit

3,573

6,919

Income from continuing operations

206

113

Net income

206

113

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Trademarks and Other Intangibles
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Trademarks and Other Intangibles

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

June 30, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

24,391

 

44,489

Copyrights and other intellectual property

 

8 years

 

429

 

328

 

101

Total

$

69,309

$

24,719

$

44,590

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

Amortization expense for intangible assets was approximately $1.54 million for both the three-month period ended June 30, 2023 (the "current quarter") and the three-month period ended June 30, 2022 (the "prior year quarter").

Amortization expense for intangible assets was approximately $3.07 million for both the six-month period ended June 30, 2023 (the "current six months") and the six-month period ended June 30, 2022 (the "prior year six months").

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Contracts
3 Months Ended
Mar. 31, 2023
Risks and Uncertainties [Abstract]  
Significant Contracts and Concentrations

4.      Significant Contracts and Concentrations

Halston Master License

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. The licensee has

an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.89 million of deferred revenue contract liabilities on its condensed consolidated balance sheet as of June 30, 2023 related to this contract, of which $0.89 million was classified as a current liability and $4.00 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 5.5 years. Net licensing revenue recognized from the Halston Master License was $0.33 million for the current quarter and current six months.

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.76 million and $4.05 million for the current quarter and prior year quarter, respectively, representing approximately 26% and 48% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year quarter included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.
Net licensing revenue from the Qurate Agreements totaled $3.28 million and $9.06 million for the current six months and prior year six months, respectively, representing approximately 26% and 53% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year six months included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.
As of June 30, 2023 and December 31, 2022, the Company had receivables from Qurate of $1.6 million and $0.9 million, respectively, representing approximately 23% and 17% of the Company’s total net accounts receivable, respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts Receivable
6 Months Ended
Jun. 30, 2023
Accounts Receivable [Abstract]  
Accounts Receivable

5. Accounts Receivable

Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances for credit losses. Such allowances were approximately $0.0 million as of both June 30, 2023 and December 31, 2022. The Company did not recognize any credit loss expense in the current quarter or current six months. There were no significant write-offs or recoveries in the current quarter or current six months.

Credit loss expense recognized in the prior year quarter and prior year six months was $0.09 million.

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

Also, as of June 30, 2023 and December 31, 2022, approximately $1.18 million and $1.65 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the third quarter of 2022, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During the current quarter and current six months, the Company paid approximately $0.02 million and $0.07 million in fees to the agent under the aforementioned services agreement.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Leases
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Leases

6. Leases

The Company has an operating lease for its corporate offices and operations facility, as well as certain equipment with a term of 12 months or less.  As of June 30, 2023, the Company’s real estate lease has a remaining lease term of approximately 4.3 years, and the lease liability is measured using a discount rate of 6.25%.

Lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.4 million for both the current quarter and prior year quarter, approximately $0.8 million for the current six months, and approximately $0.7 million for the prior year six months.

Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter, approximately $0.8 million in the current six months, and approximately $1.0 million in the prior year six months.

Also, the Company was previously a party to an operating lease for its former retail store location, which was closed in 2022. During the three months ended June 30, 2023, the Company successfully negotiated a settlement with the lessor resulting in the termination of this lease. Under the settlement agreement, the Company paid $0.07 million to the lessor in May 2023, and agreed to make two subsequent payments of approximately $0.11 million each to the lessor on or before July 31, 2023 and October 31, 2023. The Company recognized a liability of $0.23 million for these remaining payments as part of “accounts payable, accrued expenses and other current liabilities” on the condensed consolidated balance sheet as of June 30, 2023. The Company recognized a gain of $0.44 million from this settlement transaction, which is classified within “other expense (income), including non-cash expenses” in the condensed consolidated statements of operations for the three and six months ended June 30, 2023.

As of June 30, 2023, the maturities of lease obligations were as follows:

($ in thousands)

    

2023 (July 1 through December 31)

$

776

2024

1,552

2025

 

1,552

2026

 

1,552

2027

 

1,294

Thereafter

 

-

Total lease payments

6,726

Less: Discount

847

Present value of lease liabilities

5,879

Current portion of lease liabilities

1,219

Non-current portion of lease liabilities

$

4,660

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Debt
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Debt

7. Debt

The Company did not have any debt obligations as of June 30, 2023 or December 31, 2022.

From December 30, 2021 through May 31, 2022, the Company had term loan debt outstanding pursuant to an agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”); this debt was repaid in full and extinguished on May 31, 2022. As a result of this extinguishment, the Company recognized a loss on early extinguishment of debt of approximately $2.3 million during the prior year quarter and prior year six months, consisting of approximately $1.4 million of debt prepayment premium, the immediate write-off of approximately $0.8 million of unamortized deferred finance costs, and approximately $0.1 million of other costs.

For the prior year quarter and prior year six months, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.48 million and $1.19 million, respectively, and the effective interest rate related to term loan debt was approximately 9.8%.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

8. Stockholders’ Equity

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures

are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized in the current quarter and prior year quarter for all forms of stock-based compensation was approximately $0.06 million and $0.58 million, respectively. Of the current quarter expense amount, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Of the prior year quarter expense amount, approximately $0.39 million related to employees and approximately $0.19 million related to directors and consultants. Approximately $0.48 million of the prior year quarter expense was recorded as operating costs, and approximately $0.10 million was recorded as a reduction to other income.

Total expense recognized in the current six months and prior year six months for all forms of stock-based compensation was approximately $0.12 million and $0.61 million, respectively. Of the current six months expense amount, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Of the prior year six months expense amount, approximately $0.40 million related to employees and approximately $0.21 million related to directors and consultants. Approximately $0.51 million of the prior year six months expense was recorded as operating costs, and approximately $0.10 million was recorded as a reduction to other income.

Stock Options

A summary of the Company’s stock options activity for the current six months is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

 

 

  

 

  

Exercised

 

(22,750)

 

1.00

 

  

 

  

Expired/Forfeited

 

(472,140)

 

3.84

 

  

 

  

Outstanding at June 30, 2023, and expected to vest

 

5,119,420

$

2.04

 

4.59

$

Exercisable at June 30, 2023

 

1,556,920

$

2.76

 

2.19

$

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.38 million, respectively. Compensation expense related to stock options for the current six months and the prior year six months was approximately $0.05 million and $0.40 million, respectively. Total unrecognized compensation expense related to unvested stock options at June 30, 2023 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.79 years.

A summary of the Company’s non-vested stock options activity for the current six months is as follows:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

 

Vested

 

(135,000)

0.68

Forfeited or Canceled

 

 

Balance at June 30, 2023

 

3,562,500

$

0.02

Warrants

A summary of the Company’s warrants activity for the current six months is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

1,000,000

 

1.50

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at June 30, 2023

 

1,116,065

$

1.67

 

8.97

$

88,009

Exercisable at June 30, 2023

 

116,065

$

3.15

 

1.09

$

On May 15, 2023, in connection with the Halston Master License (see Note 4), the Company issued to a licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied under the license agreement. The fair value of the warrants will be recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital.

No compensation expense related to warrants was recognized in the current quarter, prior year quarter, current six months, or prior year six months.

Stock Awards

A summary of the Company’s restricted stock activity for the current six months is as follows:  

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

66,668

 

0.67

Vested

 

(66,668)

 

0.67

Expired/Forfeited

 

 

Outstanding at June 30, 2023

 

333,333

$

3.71

On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On April 17, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

On May 15, 2023, the Company issued 50,000 shares of common stock to a consultant, which vested immediately.

Compensation expense related to stock awards was approximately $0.05 million for the current quarter and approximately $0.20 million for the prior year quarter. Compensation expense related to stock awards was approximately $0.08 million for the current six months and approximately $0.21 million for the prior year six months. Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2023 was approximately $0.03 million and is expected to be recognized over a weighted average period of approximately 0.79 years.

Restricted Stock Units

There were no restricted stock units outstanding as of June 30, 2023 and December 31, 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

As of June 30, 2023, there were 3,302,241 shares of common stock available for award grants under the 2021 Plan.

Shares Reserved for Issuance

As of June 30, 2023, there were 8,537,726 shares of common stock reserved for issuance, including 4,898,135 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 337,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,302,241 shares available for issuance under the 2021 Plan.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share
6 Months Ended
Jun. 30, 2023
Earnings (Loss) Per Share [Abstract]  
Earnings (Loss) Per Share

9.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

The following table is a reconciliation of the numerator and denominator of the basic and diluted net (loss) income per share computations for the three and six months ended June 30, 2023 and 2022:

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Numerator:

Net (loss) income attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(3,468)

$

9,490

$

(9,111)

$

6,003

Denominator:

Basic weighted average number of shares outstanding

 

19,735,500

 

19,677,243

19,684,630

 

19,624,474

 

Add: Effect of warrants

 

 

657

 

639

 

Add: Effect of stock options

136,548

131,662

Diluted weighted average number of shares outstanding

 

19,735,500

 

19,814,448

19,684,630

 

19,756,775

Basic net loss per share

$

(0.18)

$

0.48

$

(0.46)

$

0.31

Diluted net loss per share

$

(0.18)

$

0.48

$

(0.46)

$

0.30

As a result of the net loss for the current quarter and current six months, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

 

Three Months Ended

Six Months Ended

 

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Stock options

5,119,420

5,781,890

5,119,420

5,781,890

Warrants

1,116,065

116,065

1,116,065

116,065

Total

6,235,485

 

5,897,955

6,235,485

 

5,897,955

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Taxes  
Income Taxes

10.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% and 25%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively.

For the current quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 10%, partially offset by the reversal of a valuation allowance that was previously recorded in the first quarter of 2022, which decreased the effective tax rate by approximately 6%.

The estimated annual effective income tax rate for the current six months and the prior year six months was approximately 0% and 35%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively.

For the current six months, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 14%.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

11.    Related Party Transactions

IM Topco, LLC

The Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. For the three and six months ended June 30, 2023, the Company recognized service fee income related to this agreement of $75,000 and $150,000, respectively.

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed royalties to IM Topco of $400,000 per year. Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three and six months ended June 30, 2023, the estimated amount of such shortfall was approximately $60,000 and $120,000, respectively, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

12.    Commitments and Contingencies

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in Accounting Standards Codification Subtopic 805-50. Based on the performance of the Lori Goldstein brand through December 31, 2022, approximately $0.2 million of additional consideration has been earned by the seller to date, and this amount was paid to the seller in the current six months. At December 31, 2022, $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a

long-term liability. At June 30, 2023, $1.4 million of the remaining balance was recorded as a current liability and $5.0 million was recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 2), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP will be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation, and management believes the likelihood of any such payment is remote. Based on IM Topco’s earnings from May 31, 2022 through June 30, 2023 and the applicable distribution provisions, WHP earned $7.9 million in cash flow, which reduces the maximum potential purchase price adjustment to $8.1 million.

Legal Proceedings

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Method Investment (Tables)
6 Months Ended
Jun. 30, 2023
Acquisitions, Divestitures and Variable Interest Entities[Abstract]  
Summarized financial information for IM Topco

    

For the three

    

For the six

months ended

months ended

June 30,

June 30,

($ in thousands)

2023

2023

Revenues

$

3,573

$

6,919

Gross profit

3,573

6,919

Income from continuing operations

206

113

Net income

206

113

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Trademarks and Other Intangibles (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Trademarks and Other Intangibles

    

Weighted

    

    

    

 

Average

 

June 30, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

24,391

 

44,489

Copyrights and other intellectual property

 

8 years

 

429

 

328

 

101

Total

$

69,309

$

24,719

$

44,590

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Leases (Tables)
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Maturities of Lease Liabilities

($ in thousands)

    

2023 (July 1 through December 31)

$

776

2024

1,552

2025

 

1,552

2026

 

1,552

2027

 

1,294

Thereafter

 

-

Total lease payments

6,726

Less: Discount

847

Present value of lease liabilities

5,879

Current portion of lease liabilities

1,219

Non-current portion of lease liabilities

$

4,660

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Summary of Stock Option Activity

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

 

 

  

 

  

Exercised

 

(22,750)

 

1.00

 

  

 

  

Expired/Forfeited

 

(472,140)

 

3.84

 

  

 

  

Outstanding at June 30, 2023, and expected to vest

 

5,119,420

$

2.04

 

4.59

$

Exercisable at June 30, 2023

 

1,556,920

$

2.76

 

2.19

$

Summary of Stock Option Activity for Non-Vested Options

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

 

Vested

 

(135,000)

0.68

Forfeited or Canceled

 

 

Balance at June 30, 2023

 

3,562,500

$

0.02

Summary of Warrant Activity

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

1,000,000

 

1.50

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at June 30, 2023

 

1,116,065

$

1.67

 

8.97

$

88,009

Exercisable at June 30, 2023

 

116,065

$

3.15

 

1.09

$

Summary of Restricted Stock Activity

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

66,668

 

0.67

Vested

 

(66,668)

 

0.67

Expired/Forfeited

 

 

Outstanding at June 30, 2023

 

333,333

$

3.71

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings (Loss) Per Share [Abstract]  
Schedule of the basic and diluted net loss per share

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Numerator:

Net (loss) income attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(3,468)

$

9,490

$

(9,111)

$

6,003

Denominator:

Basic weighted average number of shares outstanding

 

19,735,500

 

19,677,243

19,684,630

 

19,624,474

 

Add: Effect of warrants

 

 

657

 

639

 

Add: Effect of stock options

136,548

131,662

Diluted weighted average number of shares outstanding

 

19,735,500

 

19,814,448

19,684,630

 

19,756,775

Basic net loss per share

$

(0.18)

$

0.48

$

(0.46)

$

0.31

Diluted net loss per share

$

(0.18)

$

0.48

$

(0.46)

$

0.30

Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share

 

Three Months Ended

Six Months Ended

 

June 30, 

June 30, 

    

2023

    

2022

    

2023

    

2022

Stock options

5,119,420

5,781,890

5,119,420

5,781,890

Warrants

1,116,065

116,065

1,116,065

116,065

Total

6,235,485

 

5,897,955

6,235,485

 

5,897,955

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations, Background, and Basis of Presentation (Details)
6 Months Ended
Jun. 30, 2023
May 31, 2022
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%  
Q Optix, LLC | Variable Interest Entity, Primary Beneficiary    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%  
IM Topco, LLC    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Ownership interest   30.00%
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 15, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Net (loss) income   $ (3,468)   $ 9,490   $ (9,111) $ 6,003  
Net loss   3,701 $ 5,938 $ (9,189) $ 3,739 9,639 (5,450)  
Accumulated deficit   (41,908)       (41,908)   $ (32,797)
Other Noncash Expense   1,700       4,000    
Net cash used in operating activities           1,471 8,719  
Working capital, Net   6,000       6,000    
Cash and cash equivalents   $ 3,507       3,507    
Reduction in payroll costs           6,000    
Reduction in operating expenses           $ 7,000    
Payment of long-term debt             $ 29,000  
Halston License                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Additional royalty payable term 20 years              
Halston License | Minimum                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Royalty payable term 5 years              
Halston License | Maximum                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Royalty payable term 25 years              
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Method Investment - IM Topco, LLC (Details) - USD ($)
3 Months Ended 6 Months Ended
May 27, 2023
May 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
May 27, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Gain on sale of majority interest in Isaac Mizrahi brand       $ 20,608,000   $ 20,608,000  
Loss from equity method investment         $ (1,030,000)    
IM Topco, LLC              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Ownership interest   30.00%          
IM Topco, LLC              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Loss from equity method investment     $ (520,000)   $ (1,030,000.00)    
Business Venture Agreement              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Net cash flow distributable to members (in percent)   100.00%          
Net cash flow distributable to members   $ 1,316,200          
Business Venture Agreement | WHP              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Net cash flow distributable to members (in percent)   100.00%          
Net cash flow distributable to members   $ 8,852,000          
IM Brand trademarks and other intellectual property rights | Disposed of by Sale              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Amount received in cash $ 46,200,000            
Transaction expenses 900,000            
Legal and agent fees $ 100,000            
Shares issued to consultant in connection with Isaac Mizrahi sale transaction 65,275            
Gain on sale of majority interest in Isaac Mizrahi brand           $ 20,600,000  
IM Brand trademarks and other intellectual property rights | Disposed of by Sale | IM Topco, LLC              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Ownership interest             70.00%
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Method Investment - Summarized financial information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Gross Profit $ 2,981   $ 5,897   $ 6,338 $ 12,964
Net loss (3,701) $ (5,938) $ 9,189 $ (3,739) (9,639) $ 5,450
IM Topco, LLC            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Revenues 3,573       6,919  
Gross Profit 3,573       6,919  
Loss from continuing operations 206       113  
Net loss $ 206       $ 113  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Trademarks and Other Intangibles - Narrative (Details) - USD ($)
$ in Thousands
15 Months Ended 18 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense for intangible assets $ 1,540 $ 3,070
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Trademarks and Other Intangibles    
Gross Carrying Amount (definite-lived) $ 69,309  
Gross Carrying Amount, Total   $ 69,309
Accumulated Amortization 24,719 21,644
Net Carrying Amount 44,590  
Net Carrying Amount, Total $ 44,590 $ 47,665
Trademarks (finite-lived)    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 15 years 15 years
Gross Carrying Amount (definite-lived) $ 68,880 $ 68,880
Accumulated Amortization 24,391 21,346
Net Carrying Amount $ 44,489 $ 47,534
Copyrights and other intellectual property    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 8 years 8 years
Gross Carrying Amount (definite-lived) $ 429 $ 429
Accumulated Amortization 328 298
Net Carrying Amount $ 101 $ 131
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Signifcant Contracts and Concentrations - Halson Master License (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
May 15, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Subsequent Event [Line Items]            
Purchaseable stock   19,700,656   19,700,656   19,624,860
Deferred revenue, current   $ 922   $ 922   $ 88
Deferred revenue, long-term liability   4,207   4,207    
Licensing revenue   6,781 $ 8,467 12,831 $ 17,214  
Net licensing revenue            
Subsequent Event [Line Items]            
Licensing revenue   2,428 $ 5,175 4,650 $ 11,136  
Halston License            
Subsequent Event [Line Items]            
Additional royalty payable term 20 years          
Total purchase price $ 5,000          
Warrant term 10 years          
Purchaseable stock 1,000,000          
Warrants outstanding, exercise price (in dollars per share) $ 1.50          
Deferred revenue   4,890   4,890    
Deferred revenue, current   890   890    
Deferred revenue, long-term liability   $ 4,000   $ 4,000    
Recognition period of deferred revenue       5 years 6 months    
Halston License | Minimum            
Subsequent Event [Line Items]            
Royalty payable term 5 years          
Halston License | Maximum            
Subsequent Event [Line Items]            
Royalty payable term 25 years          
Halston License | Warrants            
Subsequent Event [Line Items]            
Purchaseable stock 1,000,000          
Warrants outstanding, exercise price (in dollars per share) $ 1.50          
Halston License | Net licensing revenue            
Subsequent Event [Line Items]            
Licensing revenue       $ 330    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Contracts and Concentrations - Qurate Agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Product Information [Line Items]          
Net revenue $ 6,781 $ 8,467 $ 12,831 $ 17,214  
Accounts receivable 6,878   6,878   $ 5,110
Net licensing revenue          
Product Information [Line Items]          
Net revenue $ 2,428 $ 5,175 $ 4,650 $ 11,136  
Sales [Member] | Customer Concentration Risk [Member] | Qurate          
Product Information [Line Items]          
Concentration Risk, Percentage 26.00% 48.00% 26.00% 53.00%  
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue          
Product Information [Line Items]          
Net revenue $ 1,760 $ 4,050 $ 3,280 $ 9,060  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate          
Product Information [Line Items]          
Concentration Risk, Percentage     23.00%   17.00%
Accounts receivable $ 1,600   $ 1,600   $ 900
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts Receivable (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Accounts Receivable [Abstract]        
Allowance for doubtful accounts receivable $ 0 $ 0    
Write offs or recoveries   0    
Bad debt expense   0 $ 90  
Accounts receivable, assigned to third party agent for collection 1,180 1,180   $ 1,650
Accounts receivable, collection agent fees $ 20 $ 70    
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Leases - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended
May 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Oct. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Lessee, Lease, Description [Line Items]            
Cash payments for operating lease expense   $ 400 $ 400   $ 800 $ 1,000
Lease settlement expense $ 70          
Lease settlement payable       $ 110    
Gain on settlement of lease liability   $ 445     $ 445  
Weighted average discount rate   6.25%     6.25%  
Weighted average remaining lease term for operating leases   4 years 3 months 18 days     4 years 3 months 18 days  
Selling, general and administrative expenses            
Lessee, Lease, Description [Line Items]            
Operating lease expense   $ 400 $ 400   $ 800 $ 700
Other expense (income), including non-cash expenses            
Lessee, Lease, Description [Line Items]            
Gain on settlement of lease liability         440  
Accounts Payable and Accrued Liabilities            
Lessee, Lease, Description [Line Items]            
Lease settlement liability         $ 230  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
2023 (April 1 through December 31) $ 776  
2024 1,552  
2025 1,552  
2026 1,552  
2027 1,294  
Total lease payments 6,726  
Less: Discount 847  
Present value of lease liabilities 5,879  
Current portion of lease liabilities 1,219 $ 1,376
Non-current portion of lease liabilities $ 4,660 $ 5,839
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Debt Disclosure [Abstract]    
Unamortized deferred finance costs   $ 800
Effective interest rate (as percentage)   9.80%
Repayment of principal   $ 29,000
Prepayment fee   1,400
Loss on early extinguishment of debt $ 2,324 2,324
Other costs   100
Interest expense - term loan debt $ 479 $ 1,187
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Equity Incentive Plans (Details)
Jun. 30, 2023
shares
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 8,537,726
2011 Equity Incentive Plan | Unexercised Stock Options  
Stockholders' Equity  
Shares are granted available for issuance (in shares) 4,898,135
2021 Equity Incentive Plan  
Stockholders' Equity  
Number of common stock eligible for issuance 4,000,000
Shares are granted available for issuance (in shares) 3,302,241
Shares of common stock reserved for issuance (in shares) 3,302,241
2021 Equity Incentive Plan | Employee Stock Option [Member]  
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 337,350
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity        
Compensation expense $ 60 $ 580 $ 120 $ 610
Operating cost     $ 122 517
Costs and Expenses        
Stockholders' Equity        
Compensation expense   480   510
Other income        
Stockholders' Equity        
Compensation expense   100   100
Non Management Directors        
Stockholders' Equity        
Compensation expense   190   210
Employee        
Stockholders' Equity        
Compensation expense   $ 390   $ 400
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Stock Options (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Other disclosures            
Compensation expense $ 60,000.00   $ 580,000 $ 120,000 $ 610,000  
Employee            
Other disclosures            
Compensation expense     390,000   400,000  
Non Management Directors            
Other disclosures            
Compensation expense     190,000   210,000  
Employee Stock Option [Member]            
Number of Options            
Outstanding, beginning balance (in shares)   5,614,310   5,614,310    
Granted (in shares)       0    
Exercised (in shares)       22,750    
Expired/Forfeited (in shares)       (472,140)    
Outstanding, ending balance (in shares) 5,119,420     5,119,420   5,614,310
Exercisable (in shares)   1,556,920        
Weighted Average Exercise Price            
Outstanding, beginning balance (in dollars per share)   $ 2.12   $ 2.12    
Granted (in dollars per share)       0    
Exercised (in dollars per share)       1.00    
Expired/Forfeited (in dollars per share)       3.84    
Outstanding, ending balance (in dollars per share) $ 2.04     $ 2.04   $ 2.12
Exercisable (in dollars per share)   $ 2.76        
Other disclosures            
Outstanding Weighted Average Remaining Contractual Life (in Years)       4 years 7 months 2 days   4 years 9 months 3 days
Exercisable Weighted Average Remaining Contractual Life (in Years)   2 years 2 months 8 days        
Aggregate Intrinsic Value, Outstanding $ 0     $ 0   $ 0
Aggregate Intrinsic Value, Exercisable   $ 0        
Compensation expense 20,000.00   $ 380,000 50,000.00 $ 400,000  
Unrecognized compensation expense $ 50,000.00     $ 50,000.00    
Weighted average period of recognition       9 months 14 days    
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Non-Vested Options (Details)
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Employee Stock Option [Member]  
Number of Options  
Beginning Balance (in shares) 3,697,500
Vested (in shares) (135,000)
Ending Balance (in shares) 3,562,500
Weighted Average Grant Date Fair Value  
Beginning Balance (in dollars per share) | $ / shares $ 0.05
Vested (in dollars per share) | $ / shares 0.68
Ending Balance (in dollars per share) | $ / shares $ 0.02
Employee Stock Option [Member]  
Number of Options  
Granted (in shares) 0
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Warrants (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
May 15, 2023
Other disclosures            
Purchaseable stock 19,700,656   19,700,656   19,624,860  
Compensation expense $ 60,000.00 $ 580,000 $ 120,000 $ 610,000    
Halston License            
Other disclosures            
Warrant term           10 years
Purchaseable stock           1,000,000
Warrants outstanding, exercise price (in dollars per share)           $ 1.50
Warrants            
Number of Other than Options            
Outstanding and exercisable, beginning balance (in shares)     116,065      
Granted (in shares)     1,000,000      
Exercised (in shares)     0      
Expired/Forfeited (in shares)     0      
Outstanding, ending balance (in shares) 1,116,065   1,116,065   116,065  
Exercisable (in shares) 116,065   116,065      
Weighted Average Exercise Price            
Outstanding and exercisable, beginning balance (in dollars per share)     $ 3.15      
Granted (in dollars per share)     1.50      
Exercised (in dollars per share)     0      
Expired/Forfeited (in dollars per share)     0      
Outstanding, ending balance (in dollars per share) $ 1.67   1.67   $ 3.15  
Exercisable, ending balance (in dollars per share) $ 3.15   $ 3.15      
Weighted Average Remaining Contractual Life (in Years), Outstanding     8 years 11 months 19 days   1 year 6 months 25 days  
Weighted Average Contractual Life (in Years), Exercisable     1 year 1 month 2 days      
Aggregate Intrinsic Value, Outstanding $ 88,009   $ 88,009   $ 0  
Aggregate Intrinsic Value, Exercisable 0   0      
Other disclosures            
Compensation expense $ 0 $ 0 $ 0 $ 0    
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Stock Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
May 15, 2023
Apr. 17, 2023
Jan. 01, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Other disclosures              
Compensation expense       $ 60 $ 580 $ 120 $ 610
Non Management Directors              
Other disclosures              
Compensation expense         190   210
Employee              
Other disclosures              
Compensation expense         390   400
Restricted Stock              
Number of Other than Options              
Outstanding, beginning balance (in shares)     333,333     333,333  
Granted (in shares)           66,668  
Vested (in shares)           (66,668)  
Expired/Forfeited (in shares)           0  
Outstanding, ending balance (in shares)       333,333   333,333  
Weighted Average Exercise Price              
Outstanding, beginning balance (in dollars per share)     $ 3.71     $ 3.71  
Granted (in dollars per share)           0.67  
Vested (in dollars per share)           0.67  
Expired/Forfeited (in dollars per share)           0  
Outstanding, ending balance (in dollars per share)       $ 3.71   $ 3.71  
Other disclosures              
Unrecognized compensation expense       $ 30   $ 30  
Weighted average period of recognition           9 months 14 days  
Common Stock              
Other disclosures              
Compensation expense       $ 50 $ 200 $ 80 $ 210
Common Stock | Consultant              
Number of Other than Options              
Granted (in shares) 50,000 8,334 8,334        
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Restricted Stock (Details) - shares
Jun. 30, 2023
Dec. 31, 2022
Stockholders' Equity    
Common stock, shares outstanding (in shares) 19,700,656 19,624,860
Common stock, shares issued (in shares) 19,700,656 19,624,860
Restricted Stock    
Stockholders' Equity    
Common stock, shares outstanding (in shares) 0  
Common stock, shares issued (in shares) 0  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Earnings (Loss) Per Share [Abstract]            
Net (loss) income attributable to Xcel Brands, Inc. stockholders $ (3,468)   $ 9,490   $ (9,111) $ 6,003
Basic weighted average number of shares outstanding 19,735,500   19,677,243   19,684,630 19,624,474
Add: Effect of warrants (in shares)     657     639
Add: Effect of stock options (in shares)     136,548     131,662
Diluted weighted average number of shares outstanding 19,735,500 19,633,194 19,814,448 19,571,119 19,684,630 19,756,775
Basic net (loss) income per share $ (0.18)   $ 0.48   $ (0.46) $ 0.31
Diluted net (loss) income per share $ (0.18) $ (0.29) $ 0.48 $ (0.18) $ (0.46) $ 0.30
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Dilutive securities 6,235,485 5,897,955 6,235,485 5,897,955
Employee Stock Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Dilutive securities 5,119,420 5,781,890 5,119,420 5,781,890
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Dilutive securities 1,116,065 116,065 1,116,065 116,065
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Taxes          
Effective income tax rate 0.00% 25.00%   0.00% 35.00%
Income tax (benefit) provision $ 0 $ 3,178   $ 0 $ 3,178
Effect of state taxes on effective tax rate   10.00%     14.00%
Effect of reversal of valuation allowance     6.00%    
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions - Isaac Mizrahi (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
May 31, 2022
Restricted Stock      
Asset Purchase Agreement      
Number of shares vested   66,668  
IM Topco [Member] | License Agreement      
Asset Purchase Agreement      
Royalty guarantees $ 400,000 $ 400,000  
Recognized royalty expense 60,000 120,000  
Related Party [Member] | IM Topco [Member] | Services Agreement      
Asset Purchase Agreement      
Due from related party     $ 300,000
Revenue from services provided $ 75,000 $ 150,000  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended 13 Months Ended
May 31, 2022
USD ($)
item
Apr. 01, 2021
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2023
USD ($)
Commitments and Contingencies                
Weighted average remaining lease term for operating leases     4 years 3 months 18 days   4 years 3 months 18 days     4 years 3 months 18 days
Weighted average discount rate     6.25%   6.25%     6.25%
Cash payments for operating lease expense     $ 400 $ 400 $ 800 $ 1,000    
Contingent obligation     4,996   4,996   $ 6,396 $ 4,996
Earn-out balance before settlement     1,400   1,400   243 1,400
Additional consideration is payable to the seller             200  
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale                
Commitments and Contingencies                
Number of consecutive quarters for royalty payable term | item 4              
Royalty payable term 3 years              
Contingent obligation $ 0              
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | WHP                
Commitments and Contingencies                
WHP earned in cashflow               7,900
Adjustments to purchase price payable     8,100   8,100     8,100
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | Maximum                
Commitments and Contingencies                
Royalty guarantees 13,300              
Adjustments to purchase price payable $ 16,000              
Lori Goldstein Brand                
Commitments and Contingencies                
Contingent consideration   $ 12,500            
Contingent obligation             6,400  
Earn-out balance before settlement     $ 1,400   $ 1,400   200 $ 1,400
Royalties earned         6 years      
Contingent obligation (Lori Goldstein Earn-Out)         $ 5,000   $ 6,600  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
May 15, 2023
Jun. 30, 2023
Dec. 31, 2022
May 27, 2022
Subsequent Event [Line Items]        
Purchaseable stock   19,700,656 19,624,860  
IM Intellectual Property | Disposed of by Sale | IM Topco, LLC        
Subsequent Event [Line Items]        
Ownership interest       70.00%
Halston License        
Subsequent Event [Line Items]        
Additional royalty payable term 20 years      
Total purchase price $ 5.0      
Warrant term 10 years      
Purchaseable stock 1,000,000      
Warrants outstanding, exercise price (in dollars per share) $ 1.50      
Halston License | Minimum        
Subsequent Event [Line Items]        
Royalty payable term 5 years      
Halston License | Maximum        
Subsequent Event [Line Items]        
Royalty payable term 25 years      
Halston License | Warrants        
Subsequent Event [Line Items]        
Purchaseable stock 1,000,000      
Warrants outstanding, exercise price (in dollars per share) $ 1.50      
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Accounts Receivable 10K (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]        
Accounts receivable $ 6,878 $ 6,878   $ 5,110
Allowance for doubtful accounts 0 0    
Bad debt expense   0 $ 90  
Accounts receivable, assigned to third party agent for collection 1,180 1,180   $ 1,650
Accounts receivable, collection agent fees $ 20 $ 70    
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Pay vs Performance Disclosure        
Net Income (Loss) $ (3,468) $ 9,490 $ (9,111) $ 6,003
XML 61 xelb-20230630x10q_htm.xml IDEA: XBRL DOCUMENT 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 0001083220 xelb:HalstonBrandMember srt:MinimumMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember srt:MaximumMember 2023-05-15 2023-05-15 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 2022-05-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember xelb:ImWhpLlcMember 2022-06-01 2023-06-30 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 2022-05-31 0001083220 2023-07-01 2023-10-31 0001083220 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-01-01 2023-06-30 0001083220 2023-05-01 2023-05-31 0001083220 xelb:HalstonBrandMember 2023-01-01 2023-06-30 0001083220 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2021-04-01 2021-04-01 0001083220 xelb:LoriGoldsteinBrandMember 2023-01-01 2023-06-30 0001083220 xelb:LoriGoldsteinBrandMember 2022-01-01 2022-12-31 0001083220 2022-01-01 2022-12-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember xelb:ImWhpLlcMember 2023-06-30 0001083220 xelb:HalstonBrandMember 2023-05-15 2023-05-15 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:QOptixLlcMember 2023-01-01 2023-06-30 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember 2023-01-01 2023-06-30 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001083220 srt:DirectorMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001083220 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001083220 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001083220 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001083220 us-gaap:RetainedEarningsMember 2023-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2023-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001083220 us-gaap:RetainedEarningsMember 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001083220 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2022-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001083220 us-gaap:RetainedEarningsMember 2022-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2022-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001083220 us-gaap:RetainedEarningsMember 2022-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001083220 2022-03-31 0001083220 us-gaap:RetainedEarningsMember 2021-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2021-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001083220 xelb:ConsultantsMember 2022-04-01 2022-06-30 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001083220 srt:ExecutiveOfficerMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001083220 us-gaap:CommonStockMember 2023-06-30 0001083220 us-gaap:CommonStockMember 2023-03-31 0001083220 us-gaap:CommonStockMember 2022-12-31 0001083220 us-gaap:CommonStockMember 2022-06-30 0001083220 us-gaap:CommonStockMember 2022-03-31 0001083220 us-gaap:CommonStockMember 2021-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-03-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2011Member 2023-06-30 0001083220 us-gaap:RestrictedStockMember 2022-12-31 0001083220 xelb:ConsultantMember us-gaap:CommonStockMember 2023-05-15 2023-05-15 0001083220 xelb:ConsultantMember us-gaap:CommonStockMember 2023-04-17 2023-04-17 0001083220 xelb:ConsultantMember us-gaap:CommonStockMember 2023-01-01 2023-01-01 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-06-30 0001083220 srt:MaximumMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-04-01 2023-06-30 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-01-01 2023-06-30 0001083220 xelb:ImTopcoMember us-gaap:RelatedPartyMember xelb:ServicesAgreementMember 2023-04-01 2023-06-30 0001083220 xelb:ImTopcoMember us-gaap:RelatedPartyMember xelb:ServicesAgreementMember 2023-01-01 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001083220 us-gaap:ProductMember 2023-04-01 2023-06-30 0001083220 us-gaap:LicenseMember 2023-04-01 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001083220 xelb:HalstonBrandMember us-gaap:LicenseMember 2023-01-01 2023-06-30 0001083220 us-gaap:ProductMember 2023-01-01 2023-06-30 0001083220 us-gaap:LicenseMember 2023-01-01 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001083220 us-gaap:ProductMember 2022-04-01 2022-06-30 0001083220 us-gaap:LicenseMember 2022-04-01 2022-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001083220 us-gaap:ProductMember 2022-01-01 2022-06-30 0001083220 us-gaap:LicenseMember 2022-01-01 2022-06-30 0001083220 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001083220 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001083220 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001083220 xelb:ImTopcoMember us-gaap:RelatedPartyMember xelb:ServicesAgreementMember 2022-05-31 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001083220 xelb:IMTopcoLLCMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember 2023-04-01 2023-06-30 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-06-30 0001083220 xelb:IMTopcoLLCMember 2023-04-01 2023-06-30 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-06-30 0001083220 us-gaap:OtherExpenseMember 2023-01-01 2023-06-30 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-01-01 2022-06-30 0001083220 us-gaap:TrademarksMember 2023-06-30 0001083220 us-gaap:IntellectualPropertyMember 2023-06-30 0001083220 us-gaap:TrademarksMember 2022-12-31 0001083220 us-gaap:IntellectualPropertyMember 2022-12-31 0001083220 xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-27 0001083220 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-06-30 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2023-05-27 2023-05-27 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2023-05-27 0001083220 xelb:HalstonBrandMember 2023-06-30 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001083220 us-gaap:RestrictedStockMember 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember xelb:EquityIncentivePlan2021Member 2023-06-30 0001083220 xelb:EquityIncentivePlan2021Member 2023-06-30 0001083220 us-gaap:WarrantMember 2023-06-30 0001083220 us-gaap:WarrantMember 2022-12-31 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-05-15 0001083220 xelb:HalstonBrandMember 2023-05-15 0001083220 2022-06-30 0001083220 2021-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2023-06-30 0001083220 xelb:LoriGoldsteinBrandMember 2022-12-31 0001083220 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001083220 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001083220 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001083220 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001083220 2022-04-01 2023-06-30 0001083220 2022-01-01 2023-06-30 0001083220 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001083220 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001083220 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001083220 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001083220 xelb:NonManagementDirectorsMember 2022-04-01 2022-06-30 0001083220 xelb:EmployeeMember 2022-04-01 2022-06-30 0001083220 xelb:CostsAndExpensesMember 2022-04-01 2022-06-30 0001083220 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001083220 us-gaap:OtherIncomeMember 2022-04-01 2022-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001083220 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001083220 xelb:NonManagementDirectorsMember 2022-01-01 2022-06-30 0001083220 xelb:EmployeeMember 2022-01-01 2022-06-30 0001083220 xelb:CostsAndExpensesMember 2022-01-01 2022-06-30 0001083220 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001083220 us-gaap:OtherIncomeMember 2022-01-01 2022-06-30 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001083220 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001083220 2022-01-01 2022-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001083220 2023-04-01 2023-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001083220 2023-01-01 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001083220 2022-04-01 2022-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001083220 2022-01-01 2022-03-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001083220 srt:ExecutiveOfficerMember us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-04-01 2022-06-30 0001083220 srt:ExecutiveOfficerMember 2022-04-01 2022-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-06-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001083220 2023-06-30 0001083220 2022-12-31 0001083220 2023-08-09 0001083220 2023-01-01 2023-06-30 shares iso4217:USD iso4217:USD shares pure xelb:item -0.29 -0.18 19633194 19571119 0001083220 --12-31 2023 Q2 false 0 0 19700656 19624860 P6Y P25Y P20Y P10Y P25Y P20Y P25Y P5Y P5Y P5Y P5Y P5Y6M 10-Q true 2023-06-30 false 001-37527 XCEL BRANDS, INC. DE 76-0307819 1333 Broadway, 10th Floor New York NY 10018 347 727-2474 Common Stock, $0.001 par value per share XELB NASDAQ Yes Yes Non-accelerated Filer true false false 19707956 3507000 4608000 6878000 5110000 798000 2845000 554000 1457000 11737000 14020000 916000 1418000 4946000 5420000 44590000 47665000 18165000 19195000 1107000 1107000 25000 110000 69749000 74915000 81486000 88935000 2750000 3870000 922000 88000 555000 568000 154000 416000 1219000 1376000 1400000 243000 7000000 6561000 4660000 5839000 4207000 4996000 6396000 13863000 12235000 20863000 18796000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 50000000 50000000 19700656 19624860 20000 20000 103715000 103592000 -41908000 -32797000 61827000 70815000 -1204000 -676000 60623000 70139000 81486000 88935000 2428000 5175000 4650000 11136000 4353000 3292000 8181000 6078000 6781000 8467000 12831000 17214000 3800000 2570000 6493000 4250000 2981000 5897000 6338000 12964000 2241000 5236000 5706000 10089000 2943000 4288000 6436000 7712000 5184000 9524000 12142000 17801000 -2203000 -3627000 -5804000 -4837000 1786000 1812000 3583000 3632000 20608000 20608000 515000 1030000 351000 351000 445000 445000 -3708000 15169000 -9621000 12139000 479000 1187000 -7000 -1000 18000 -2324000 -2324000 7000 -2802000 -18000 -3511000 -3701000 12367000 -9639000 8628000 3178000 3178000 -3701000 9189000 -9639000 5450000 -233000 -301000 -528000 -553000 -3468000 9490000 -9111000 6003000 -0.18 0.48 -0.46 0.31 -0.18 0.48 -0.46 0.30 19735500 19677243 19684630 19624474 19735500 19814448 19684630 19756775 19571119 20000 103039000 -28779000 662000 74942000 30000 30000 -3487000 -252000 -3739000 19571119 20000 103069000 -32266000 410000 71233000 402000 402000 178727 281000 281000 53882 85000 85000 20064 33000 33000 50000 65275 97000 97000 33557 50000 50000 240000 357000 357000 9490000 -301000 9189000 19624860 20000 103490000 -22776000 109000 80843000 19624860 20000 103592000 -32797000 -676000 70139000 51000 51000 8334 6000 6000 -5643000 -295000 -5938000 19633194 20000 103649000 -38440000 -971000 64258000 27000 27000 58334 39000 39000 9128 -3468000 -233000 -3701000 19700656 20000 103715000 -41908000 -1204000 60623000 -9639000 5450000 3583000 3632000 100000 156000 122000 517000 90000 -1030000 -2324000 1384000 20608000 351000 445000 1768000 1741000 -2047000 100000 -863000 -8000 5041000 347000 -1637000 205000 -417000 -159000 -224000 -1471000 -8719000 45408000 451000 81000 85000 370000 45323000 442000 29000000 1511000 -30953000 -1101000 5651000 4608000 5222000 3507000 10873000 1032000 16000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">1. Nature of Operations, Background, and Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying condensed consolidated balance sheet as of December 31, 2022 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands. </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company manages the Longaberger Brand through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company manages the Q Optix business through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in Q Optix, LLC; the Company consolidates Q Optix, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in IM Topco, LLC, and continues to contribute to the operations of the brand through a service agreement (see Note 11 for additional details). The Company accounts for its interest in IM Topco, LLC using the equity method of accounting.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company designs, produces, markets, and distributes products, licenses its brands to third parties, and generates licensing revenues through contractual arrangements with manufacturers and retailers. The Company and its licensees distribute through an omni-channel retail sales strategy, which includes distribution through interactive television, digital live-stream shopping, wholesale, and e-commerce channels to be everywhere its customers shop.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Condensed Consolidated Statements of Operations, separately from the Company’s net licensing revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Management’s Plans  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company incurred a net loss attributable to Company stockholders of approximately $3.5 million and $9.1 million during the three and six months ended June 30, 2023, respectively (which included net non-cash expenses of approximately $1.7 million and $4.0 million, respectively), and had an accumulated deficit of approximately $41.9 million as of June 30, 2023. Net cash used in operating activities was approximately $1.5 million for the six months ended June 30, 2023. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent obligations payable in common stock) of approximately $6.0 million as of June 30, 2023. The Company’s cash and cash equivalents were approximately $3.5 million as of June 30, 2023. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to develop and launch in 2023 and beyond. For the Halston Brand, on May 15, 2023, the Company entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 4). This new master license for the Halston Brand provides for an upfront cash payment and royalties, including certain guaranteed minimum royalties to the Company, includes significant annual minimum net sales requirements, and has a <span style="-sec-ix-hidden:Hidden_bvJ6K_zwrkSNnsb2wNvA6Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five</span></span>-year term (consisting of an initial <span style="-sec-ix-hidden:Hidden_8EjgcnI76Ua_PHMYXp1hcQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>-year period, followed by a <span style="-sec-ix-hidden:Hidden_nIyn33YIjU2zuUEoFEm6bw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty</span></span>-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each <span style="-sec-ix-hidden:Hidden_rHs5kdGSLEC50QTYtvh4Pg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>-year period during the term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The transition of these operating businesses was substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of June 30, 2023, the Company has reduced payroll costs by approximately $6 million and operating expenses by approximately $7 million, on an annualized basis when compared to the corresponding periods in the prior year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Based on these recent events and changes in the Company’s business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of June 30, 2023, have been alleviated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.</p> 0.50 0.50 0.30 -3500000 -9100000 1700000 4000000.0 -41900000 -1500000 6000000.0 3500000 6000000 7000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">2.      Equity Method Investment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold </span><span style="font-weight:normal;">70%</span><span style="font-weight:normal;"> of the membership interests of IM Topco to WHP. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The purchase price paid by WHP to the Company at the closing of the transaction consisted of $46.2 million in cash. The Company incurred approximately $0.9 million of expenses directly related to this transaction, including legal fees and agent fees, of which $0.1 million of the agent fees were paid through the issuance of 65,275 shares of the Company’s common stock, which were recognized as a reduction to the gain from the transaction. The Company recognized a net pre-tax gain from the transaction of $20.6 million, which is classified within “other expense (income), including non-cash expenses” in the condensed consolidated statements of operations for the three and six months ended June 30, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its 30% interest in the ongoing operations of IM Topco as other expense (income) under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">first, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to WHP, until WHP has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$8,852,000 </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(subject to adjustment in certain circumstances as set forth in the agreement); </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">second, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,316,200</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (subject to adjustment in certain circumstances as set forth in the agreement); and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">thereafter, in proportion to the members’ respective percentage interests.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million and $1.03 million related to its investment for the three and six months ended June 30, 2023, respectively. The Company did not recognize any equity income or loss related to its investment for the three and six months ended June 30, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Summarized financial information for IM Topco for the three and six months ended June 30, 2023 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the six</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:14.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,919</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,919</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 0.70 46200000 900000 100000 65275 20600000 0.30 1 8852000 1 1316200 -520000 -1030000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the six</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">months ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:14.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,919</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,919</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113</p></td></tr></table> 3573000 6919000 3573000 6919000 206000 113000 206000 113000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">3.      Trademarks and Other Intangibles   </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Trademarks and other intangibles, net consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,391</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,489</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 101</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,719</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 44,590</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,534</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,644</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 47,665</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Amortization expense for intangible assets was approximately $1.54 million for both the three-month period ended June 30, 2023 (the "current quarter") and the three-month period ended June 30, 2022 (the "prior year quarter").</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Amortization expense for intangible assets was approximately $3.07 million for both the six-month period ended June 30, 2023 (the "current six months") and the six-month period ended June 30, 2022 (the "prior year six months").</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,391</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,489</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 101</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 24,719</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 44,590</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,534</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,644</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 47,665</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> P15Y 68880000 24391000 44489000 P8Y 429000 328000 101000 69309000 24719000 44590000 P15Y 68880000 21346000 47534000 P8Y 429000 298000 131000 69309000 21644000 47665000 1540000 3070000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">4.      Significant Contracts and Concentrations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Halston Master License</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-style:normal;font-weight:normal;">On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a </span><span style="-sec-ix-hidden:Hidden_9uODRonC8U2xbXafcngOLg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five</span></span><span style="font-style:normal;font-weight:normal;">-year term (consisting of an initial </span><span style="-sec-ix-hidden:Hidden_qfcuo_ZRikatD7ksKgFJ8g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span><span style="font-style:normal;font-weight:normal;">-year period, followed by a </span><span style="-sec-ix-hidden:Hidden_o-PXyXCc-kSOjlXxzmAJqA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty</span></span><span style="font-style:normal;font-weight:normal;">-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each </span><span style="-sec-ix-hidden:Hidden_DgFIY0h16ESzlxYu2VjP2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span><span style="font-style:normal;font-weight:normal;">-year period during the term. The licensee has </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">an option to purchase the Halston Brand for </span><span style="font-style:normal;font-weight:normal;">$5.0</span><span style="font-style:normal;font-weight:normal;"> million at the end of the </span><span style="-sec-ix-hidden:Hidden_KhRECB7UFUW0N8zeH0Qqow;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five</span></span><span style="font-style:normal;font-weight:normal;">-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a </span><span style="-sec-ix-hidden:Hidden_5_eNQi9cx0661m7fMKUkoA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ten</span></span><span style="font-style:normal;font-weight:normal;">-year warrant to purchase up to </span><span style="font-style:normal;font-weight:normal;">1,000,000</span><span style="font-style:normal;font-weight:normal;"> shares of the Company’s common stock at an exercise price of </span><span style="font-style:normal;font-weight:normal;">$1.50</span><span style="font-style:normal;font-weight:normal;"> per share, which vest based upon certain annual royalty targets being satisfied. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.89 million of deferred revenue contract liabilities on its condensed consolidated balance sheet as of June 30, 2023 related to this contract, of which $0.89 million was classified as a current liability and $4.00 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next <span style="-sec-ix-hidden:Hidden_O3ynoeQTy0-SghiP7h80Xw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5.5 years</span></span>. Net licensing revenue recognized from the Halston Master License was $0.33 million for the current quarter and current six months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Qurate Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Net licensing revenue from the Qurate Agreements totaled </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1.76</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$4.05</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the current quarter and prior year quarter, respectively, representing approximately </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">26%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">48%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year quarter included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Net licensing revenue from the Qurate Agreements totaled </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3.28</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$9.06</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the current six months and prior year six months, respectively, representing approximately </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">26%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">53%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year six months included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As of June 30, 2023 and December 31, 2022, the Company had receivables from Qurate of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1.6</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.9</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million, respectively, representing approximately </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">23%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">17%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Company’s total net accounts receivable, respectively.</span></td></tr></table> 5000000.0 1000000 1.50 4890000 890000 4000000.00 330000 1760000 4050000.00 0.26 0.48 3280000 9060000.00 0.26 0.53 1600000 900000 0.23 0.17 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">5. Accounts Receivable </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances for credit losses. Such allowances were approximately $0.0 million as of both June 30, 2023 and December 31, 2022. The Company did not recognize any credit loss expense in the current quarter or current six months. There were no significant write-offs or recoveries in the current quarter or current six months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Credit loss expense recognized in the prior year quarter and prior year six months was $0.09 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Also, as of June 30, 2023 and December 31, 2022, approximately $1.18 million and $1.65 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the third quarter of 2022, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During the current quarter and current six months, the Company paid approximately $0.02 million and $0.07 million in fees to the agent under the aforementioned services agreement. </p> 0.0 0 0 90000.00 1180000 1650000 20000.00 70000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">6. Leases </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company has an operating lease for its corporate offices and operations facility, as well as certain equipment with a term of 12 months or less.  As of June 30, 2023, the Company’s real estate lease has a remaining lease term of approximately 4.3 years, and the lease liability is measured using a discount rate of 6.25%. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.4 million for both the current quarter and prior year quarter, approximately $0.8 million for the current six months, and approximately $0.7 million for the prior year six months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter, approximately $0.8 million in the current six months, and approximately $1.0 million in the prior year six months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Also, the Company was previously a party to an operating lease for its former retail store location, which was closed in 2022. During the three months ended June 30, 2023, the Company successfully negotiated a settlement with the lessor resulting in the termination of this lease. Under the settlement agreement, the Company paid $0.07 million to the lessor in May 2023, and agreed to make two subsequent payments of approximately $0.11 million each to the lessor on or before July 31, 2023 and October 31, 2023. The Company recognized a liability of $0.23 million for these remaining payments as part of “accounts payable, accrued expenses and other current liabilities” on the condensed consolidated balance sheet as of June 30, 2023. The Company recognized a gain of $0.44 million from this settlement transaction, which is classified within “other expense (income), including non-cash expenses” in the condensed consolidated statements of operations for the three and six months ended June 30, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of June 30, 2023, the maturities of lease obligations were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023 (July 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">776</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,294</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">6,726</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">847</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,879</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,219</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,660</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> P4Y3M18D 0.0625 400000 400000 800000 700000 400000 400000 800000 1000000.0 70000.00 110000 230000 440000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023 (July 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">776</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,294</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> -</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">6,726</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">847</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,879</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,219</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,660</p></td></tr></table> 776000 1552000 1552000 1552000 1294000 6726000 847000 5879000 1219000 4660000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">7. Debt</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company did not have any debt obligations as of June 30, 2023 or December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">From December 30, 2021 through May 31, 2022, the Company had term loan debt outstanding pursuant to an agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”); this debt was repaid in full and extinguished on May 31, 2022. As a result of this extinguishment, the Company recognized a loss on early extinguishment of debt of approximately $2.3 million during the prior year quarter and prior year six months, consisting of approximately $1.4 million of debt prepayment premium, the immediate write-off of approximately $0.8 million of unamortized deferred finance costs, and approximately $0.1 million of other costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">For the prior year quarter and prior year six months, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.48 million and $1.19 million, respectively, and the effective interest rate related to term loan debt was approximately 9.8%.</p> -2300000 1400000 800000 100000 480000 1190000 0.098 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:9.35pt;text-indent:-9.35pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:9.25pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span><b style="font-weight:bold;white-space:pre-wrap;"> Stockholders’ Equity </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock-based Compensation </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total expense recognized in the current quarter and prior year quarter for all forms of stock-based compensation was approximately $0.06 million and $0.58 million, respectively. Of the current quarter expense amount, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Of the prior year quarter expense amount, approximately $0.39 million related to employees and approximately $0.19 million related to directors and consultants. Approximately $0.48 million of the prior year quarter expense was recorded as operating costs, and approximately $0.10 million was recorded as a reduction to other income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total expense recognized in the current six months and prior year six months for all forms of stock-based compensation was approximately $0.12 million and $0.61 million, respectively. Of the current six months expense amount, substantially all of the expense related to directors and consultants, and was recorded within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Of the prior year six months expense amount, approximately $0.40 million related to employees and approximately $0.21 million related to directors and consultants. Approximately $0.51 million of the prior year six months expense was recorded as operating costs, and approximately $0.10 million was recorded as a reduction to other income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s stock options activity for the current six months is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (22,750)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (472,140)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at June 30, 2023, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,119,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,556,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.38 million, respectively. Compensation expense related to stock options for the current six months and the prior year six months was approximately $0.05 million and $0.40 million, respectively. Total unrecognized compensation expense related to unvested stock options at June 30, 2023 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.79 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s non-vested stock options activity for the current six months is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (135,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.68</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,562,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s warrants activity for the current six months is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88,009</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On May 15, 2023, in connection with the Halston Master License (see Note 4), the Company issued to a licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied under the license agreement. The fair value of the warrants will be recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">No compensation expense related to warrants was recognized in the current quarter, prior year quarter, current six months, or prior year six months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Stock Awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s restricted stock activity for the current six months is as follows:  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 66,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.67</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (66,668)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.67</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On April 17, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On May 15, 2023, the Company issued 50,000 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Compensation expense related to stock awards was approximately $0.05 million for the current quarter and approximately $0.20 million for the prior year quarter. Compensation expense related to stock awards was approximately $0.08 million for the current six months and approximately $0.21 million for the prior year six months. Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2023 was approximately $0.03 million and is expected to be recognized over a weighted average period of approximately 0.79 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Restricted Stock Units</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">There were no restricted stock units outstanding as of June 30, 2023 and December 31, 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Available Under the Company’s Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of June 30, 2023, there were 3,302,241 shares of common stock available for award grants under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Reserved for Issuance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of June 30, 2023, there were 8,537,726 shares of common stock reserved for issuance, including 4,898,135 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 337,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,302,241 shares available for issuance under the 2021 Plan.</p> 4000000 60000.00 580000 390000 190000 480000 100000 120000 610000 400000 210000 510000 100000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (22,750)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (472,140)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at June 30, 2023, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,119,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,556,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> 5614310 2.12 P4Y9M3D 0 0 0 22750 1.00 472140 3.84 5119420 2.04 P4Y7M2D 0 1556920 2.76 P2Y2M8D 0 20000.00 380000 50000.00 400000 50000.00 P0Y9M14D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (135,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.68</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,562,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td></tr></table> 3697500 0.05 135000 0.68 3562500 0.02 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88,009</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr></table> 116065 3.15 P1Y6M25D 0 1000000 1.50 0 0 0 0 1116065 1.67 P8Y11M19D 88009 116065 3.15 P1Y1M2D 0 P10Y 1000000 1.50 0 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 66,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.67</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (66,668)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.67</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at June 30, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr></table> 333333 3.71 66668 0.67 66668 0.67 0 0 333333 3.71 8334 8334 50000 50000.00 200000 80000.00 210000 30000.00 P0Y9M14D 0 0 3302241 8537726 4898135 337350 3302241 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10.1pt;text-indent:-10.1pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">9.    </b><b style="font-weight:bold;white-space:pre-wrap;">Earnings (Loss) Per Share </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table is a reconciliation of the numerator and denominator of the basic and diluted net (loss) income per share computations for the three and six months ended June 30, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:24.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Six Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net (loss) income attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,468)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,111)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,003</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,735,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,677,243</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,684,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,624,474</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 657</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 639</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 136,548</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131,662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,735,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,814,448</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,684,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,756,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.48</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.46)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted net loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.48</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.46)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As a result of the net loss for the current quarter and current six months, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Six Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,119,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,781,890</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,119,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,781,890</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,235,485</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,897,955</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,235,485</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,897,955</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:24.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Six Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net (loss) income attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,468)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,490</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,111)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,003</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,735,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,677,243</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,684,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,624,474</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 657</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 639</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 136,548</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131,662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,735,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,814,448</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,684,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,756,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.48</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.46)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted net loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.48</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.46)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> -3468000 9490000 -9111000 6003000 19735500 19677243 19684630 19624474 657 639 136548 131662 19735500 19814448 19684630 19756775 -0.18 0.48 -0.46 0.31 -0.18 0.48 -0.46 0.30 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Six Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,119,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,781,890</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,119,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,781,890</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,235,485</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,897,955</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,235,485</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,897,955</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr></table> 5119420 5781890 5119420 5781890 1116065 116065 1116065 116065 6235485 5897955 6235485 5897955 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">10.    Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% and 25%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the current quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 10%, partially offset by the reversal of a valuation allowance that was previously recorded in the first quarter of 2022, which decreased the effective tax rate by approximately 6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The estimated annual effective income tax rate for the current six months and the prior year six months was approximately 0% and 35%, respectively, resulting in an income tax (benefit) provision of $0 and $3.18 million, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the current six months, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to recurring permanent differences, state taxes, and the discrete treatment of stock compensation shortfall, which increased the effective tax rate by approximately 14%.</p> 0 0.25 0 3180000 0.10 0.06 0 0.35 0 3180000 0.14 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">11.    Related Party Transactions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. For the three and six months ended June 30, 2023, the Company recognized service fee income related to this agreement of $75,000 and $150,000, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed royalties to IM Topco of $400,000 per year. Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three and six months ended June 30, 2023, the estimated amount of such shortfall was approximately $60,000 and $120,000, respectively, which the Company recognized as royalty expense in the condensed consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 300000 75000 150000 400000 60000 120000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">12.    Commitments and Contingencies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Lori Goldstein Earn-Out</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the <span style="-sec-ix-hidden:Hidden_7HcNofzud02vEAZWx0wjiw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">six</span></span> calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in Accounting Standards Codification Subtopic 805-50. Based on the performance of the Lori Goldstein brand through December 31, 2022, approximately $0.2 million of additional consideration has been earned by the seller to date, and this amount was paid to the seller in the current six months. At December 31, 2022, $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">long-term liability. At June 30, 2023, $1.4 million of the remaining balance was recorded as a current liability and $5.0 million was recorded as a long-term liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Isaac Mizrahi Transaction</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 2), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP will be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation, and management believes the likelihood of any such payment is remote. Based on IM Topco’s earnings from May 31, 2022 through June 30, 2023 and the applicable distribution provisions, WHP earned $7.9 million in cash flow, which reduces the maximum potential purchase price adjustment to $8.1 million. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Legal Proceedings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.</p> 12500000 6600000 200000 200000 6400000 1400000 5000000.0 13300000 4 P3Y 16000000 0 7900000 8100000 EXCEL 62 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 63 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 183 269 1 false 52 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation Nature of Operations, Background, and Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Equity Method Investment Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 8 false false R9.htm 10301 - Disclosure - Trademarks and Other Intangibles Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles Trademarks and Other Intangibles Notes 9 false false R10.htm 10401 - Disclosure - Significant Contracts Sheet http://www.xcelbrands.com/role/DisclosureSignificantContracts Significant Contracts Notes 10 false false R11.htm 10501 - Disclosure - Accounts Receivable Sheet http://www.xcelbrands.com/role/DisclosureAccountsReceivable Accounts Receivable Notes 11 false false R12.htm 10601 - Disclosure - Leases Sheet http://www.xcelbrands.com/role/DisclosureLeases Leases Notes 12 false false R13.htm 10701 - Disclosure - Debt Sheet http://www.xcelbrands.com/role/DisclosureDebt Debt Notes 13 false false R14.htm 10801 - Disclosure - Stockholders' Equity Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 10901 - Disclosure - Earnings (Loss) Per Share Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare Earnings (Loss) Per Share Notes 15 false false R16.htm 11001 - Disclosure - Income Taxes Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxes Income Taxes Notes 16 false false R17.htm 11101 - Disclosure - Related Party Transactions Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 11201 - Disclosure - Commitments and Contingencies Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 30203 - Disclosure - Equity Method Investment (Tables) Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment 19 false false R20.htm 30303 - Disclosure - Trademarks and Other Intangibles (Tables) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables Trademarks and Other Intangibles (Tables) Tables http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles 20 false false R21.htm 30603 - Disclosure - Leases (Tables) Sheet http://www.xcelbrands.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.xcelbrands.com/role/DisclosureLeases 21 false false R22.htm 30803 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.xcelbrands.com/role/DisclosureStockholdersEquity 22 false false R23.htm 30903 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare 23 false false R24.htm 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails Nature of Operations, Background, and Basis of Presentation (Details) Details http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation 24 false false R25.htm 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) Details http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation 25 false false R26.htm 40201 - Disclosure - Equity Method Investment - IM Topco, LLC (Details) Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails Equity Method Investment - IM Topco, LLC (Details) Details 26 false false R27.htm 40202 - Disclosure - Equity Method Investment - Summarized financial information (Details) Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails Equity Method Investment - Summarized financial information (Details) Details 27 false false R28.htm 40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails Trademarks and Other Intangibles - Narrative (Details) Details 28 false false R29.htm 40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Details 29 false false R30.htm 40401 - Disclosure - Signifcant Contracts and Concentrations - Halson Master License (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails Signifcant Contracts and Concentrations - Halson Master License (Details) Details 30 false false R31.htm 40402 - Disclosure - Significant Contracts and Concentrations - Qurate Agreements (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails Significant Contracts and Concentrations - Qurate Agreements (Details) Details 31 false false R32.htm 40501 - Disclosure - Accounts Receivable (Details) Sheet http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails Accounts Receivable (Details) Details http://www.xcelbrands.com/role/DisclosureAccountsReceivable 32 false false R33.htm 40601 - Disclosure - Leases - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails Leases - Narrative (Details) Details 33 false false R34.htm 40602 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 34 false false R35.htm 40701 - Disclosure - Debt - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails Debt - Narrative (Details) Details 35 false false R36.htm 40801 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails Stockholders' Equity - Equity Incentive Plans (Details) Details 36 false false R37.htm 40802 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails Stockholders' Equity - Stock-based Compensation (Details) Details 37 false false R38.htm 40803 - Disclosure - Stockholders' Equity - Stock Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails Stockholders' Equity - Stock Options (Details) Details 38 false false R39.htm 40806 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails Stockholders' Equity - Non-Vested Options (Details) Details 39 false false R40.htm 40807 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 40 false false R41.htm 40808 - Disclosure - Stockholders' Equity - Stock Awards (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails Stockholders' Equity - Stock Awards (Details) Details 41 false false R42.htm 40809 - Disclosure - Stockholders' Equity - Restricted Stock (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails Stockholders' Equity - Restricted Stock (Details) Details 42 false false R43.htm 40901 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 43 false false R44.htm 40902 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 44 false false R45.htm 41003 - Disclosure - Income Taxes (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.xcelbrands.com/role/DisclosureIncomeTaxes 45 false false R46.htm 41101 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails Related Party Transactions - Isaac Mizrahi (Details) Details 46 false false R47.htm 41201 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 47 false false R48.htm 41301 - Disclosure - Subsequent Events - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails Subsequent Events - Narrative (Details) Details 48 false false R49.htm 9940202 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable 10K (Details) Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails Summary of Significant Accounting Policies - Accounts Receivable 10K (Details) Details 49 false false R50.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Uncategorized 50 false false All Reports Book All Reports xelb-20230630x10q.htm xelb-20230630.xsd xelb-20230630_cal.xml xelb-20230630_def.xml xelb-20230630_lab.xml xelb-20230630_pre.xml xelb-20230630xex31d1.htm xelb-20230630xex31d2.htm xelb-20230630xex32d1.htm xelb-20230630xex32d2.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 68 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "xelb-20230630x10q.htm": { "axisCustom": 0, "axisStandard": 26, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 556, "http://xbrl.sec.gov/dei/2023": 29 }, "contextCount": 183, "dts": { "calculationLink": { "local": [ "xelb-20230630_cal.xml" ] }, "definitionLink": { "local": [ "xelb-20230630_def.xml" ] }, "inline": { "local": [ "xelb-20230630x10q.htm" ] }, "labelLink": { "local": [ "xelb-20230630_lab.xml" ] }, "presentationLink": { "local": [ "xelb-20230630_pre.xml" ] }, "schema": { "local": [ "xelb-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] } }, "elementCount": 528, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 13, "http://www.xcelbrands.com/20230630": 11, "http://xbrl.sec.gov/dei/2023": 5, "total": 29 }, "keyCustom": 43, "keyStandard": 226, "memberCustom": 21, "memberStandard": 26, "nsprefix": "xelb", "nsuri": "http://www.xcelbrands.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_HjLYDZm3VU-pv_HQQ062IQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Significant Contracts", "menuCat": "Notes", "order": "10", "role": "http://www.xcelbrands.com/role/DisclosureSignificantContracts", "shortName": "Significant Contracts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_HjLYDZm3VU-pv_HQQ062IQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "xelb:AccountsReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Accounts Receivable", "menuCat": "Notes", "order": "11", "role": "http://www.xcelbrands.com/role/DisclosureAccountsReceivable", "shortName": "Accounts Receivable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "xelb:AccountsReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Leases", "menuCat": "Notes", "order": "12", "role": "http://www.xcelbrands.com/role/DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Debt", "menuCat": "Notes", "order": "13", "role": "http://www.xcelbrands.com/role/DisclosureDebt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "14", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "15", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "17", "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "18", "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - Equity Method Investment (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentTables", "shortName": "Equity Method Investment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_rNPb9xe_rEW_X-hcx6Y_Sg", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Trademarks and Other Intangibles (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables", "shortName": "Trademarks and Other Intangibles (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.xcelbrands.com/role/DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - Earnings (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_kUPmDok4R0uHBiHmowBFww", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_1LSBFVFGpkKBLcy9aIKi6w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details)", "menuCat": "Details", "order": "24", "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "shortName": "Nature of Operations, Background, and Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_kUPmDok4R0uHBiHmowBFww", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_1LSBFVFGpkKBLcy9aIKi6w", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity (Details)", "menuCat": "Details", "order": "25", "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "shortName": "Nature of Operations, Background, and Basis of Presentation - Liquidity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-5", "lang": null, "name": "us-gaap:OtherNoncashExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_oeTxRR-_hk-HiMtNW2zHvw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnDispositionOfAssets1", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Equity Method Investment - IM Topco, LLC (Details)", "menuCat": "Details", "order": "26", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "shortName": "Equity Method Investment - IM Topco, LLC (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_xelb_IMTopcoLLCMember_QZxs9UDOaU6uVe7okIa_Uw", "decimals": "-4", "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - Equity Method Investment - Summarized financial information (Details)", "menuCat": "Details", "order": "27", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "shortName": "Equity Method Investment - Summarized financial information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_srt_OwnershipAxis_xelb_IMTopcoLLCMember_UH6CDJFmd0Sj-8tfxVLgPA", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2023_dmxZ4vQKfUOGG8baZey4_A", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details)", "menuCat": "Details", "order": "28", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "shortName": "Trademarks and Other Intangibles - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2023_dmxZ4vQKfUOGG8baZey4_A", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "menuCat": "Details", "order": "29", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails", "shortName": "Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_-ftOb_qMn0ugDud55qrjWg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_-ftOb_qMn0ugDud55qrjWg", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_rNPb9xe_rEW_X-hcx6Y_Sg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Signifcant Contracts and Concentrations - Halson Master License (Details)", "menuCat": "Details", "order": "30", "role": "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "shortName": "Signifcant Contracts and Concentrations - Halson Master License (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_srt_CounterpartyNameAxis_xelb_HalstonBrandMember_srt_ProductOrServiceAxis_us-gaap_LicenseMember_8mRWRbc370uvL3Yc_OAkMA", "decimals": "-4", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - Significant Contracts and Concentrations - Qurate Agreements (Details)", "menuCat": "Details", "order": "31", "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails", "shortName": "Significant Contracts and Concentrations - Qurate Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_srt_MajorCustomersAxis_xelb_QurateRetailGroupMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_NuLF0vn-ckKNhFeccf6yog", "decimals": "2", "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_1LSBFVFGpkKBLcy9aIKi6w", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "xelb:AccountsReceivableTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Accounts Receivable (Details)", "menuCat": "Details", "order": "32", "role": "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "shortName": "Accounts Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "xelb:AccountsReceivableTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": "-5", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:OperatingLeasePayments", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Leases - Narrative (Details)", "menuCat": "Details", "order": "33", "role": "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_5_1_2023_To_5_31_2023_Nq6j2ryQaUG5y5r2ty6a2Q", "decimals": "-4", "lang": null, "name": "xelb:LeaseSettlementExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "menuCat": "Details", "order": "34", "role": "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_rXswCDw4MESj19QGwUhK3Q", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:WriteOffOfDeferredDebtIssuanceCost", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Debt - Narrative (Details)", "menuCat": "Details", "order": "35", "role": "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_rXswCDw4MESj19QGwUhK3Q", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:WriteOffOfDeferredDebtIssuanceCost", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details)", "menuCat": "Details", "order": "36", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "shortName": "Stockholders' Equity - Equity Incentive Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details)", "menuCat": "Details", "order": "37", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "shortName": "Stockholders' Equity - Stock-based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_xelb_CostsAndExpensesMember_09JzQvJ0JkSToQGHaDcnFw", "decimals": "-4", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40803 - Disclosure - Stockholders' Equity - Stock Options (Details)", "menuCat": "Details", "order": "38", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "shortName": "Stockholders' Equity - Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_uknZer7ZUESnvN3ePz-YEA", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_us-gaap_EmployeeStockOptionMember_VNQ_ngInB0agDSpvgwZZuA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40806 - Disclosure - Stockholders' Equity - Non-Vested Options (Details)", "menuCat": "Details", "order": "39", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "shortName": "Stockholders' Equity - Non-Vested Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_us-gaap_EmployeeStockOptionMember_VNQ_ngInB0agDSpvgwZZuA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_rNPb9xe_rEW_X-hcx6Y_Sg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40807 - Disclosure - Stockholders' Equity - Warrants (Details)", "menuCat": "Details", "order": "40", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "shortName": "Stockholders' Equity - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_WarrantMember_M7mfxVClY0mwz7tHjWPbJg", "decimals": "INF", "lang": null, "name": "xelb:ClassOfWarrantOrRightGranted", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40808 - Disclosure - Stockholders' Equity - Stock Awards (Details)", "menuCat": "Details", "order": "41", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "shortName": "Stockholders' Equity - Stock Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_dLMkxpWWXkmAYiPQfma2LA", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_rNPb9xe_rEW_X-hcx6Y_Sg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40809 - Disclosure - Stockholders' Equity - Restricted Stock (Details)", "menuCat": "Details", "order": "42", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "shortName": "Stockholders' Equity - Restricted Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_4BjeAtyevkqFIxbM3Y0aQA", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "menuCat": "Details", "order": "43", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "shortName": "Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_oeTxRR-_hk-HiMtNW2zHvw", "decimals": "INF", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "menuCat": "Details", "order": "44", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "shortName": "Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_1LSBFVFGpkKBLcy9aIKi6w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41003 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "45", "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_1LSBFVFGpkKBLcy9aIKi6w", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_dLMkxpWWXkmAYiPQfma2LA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details)", "menuCat": "Details", "order": "46", "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "shortName": "Related Party Transactions - Isaac Mizrahi (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_srt_CounterpartyNameAxis_xelb_ImTopcoMember_us-gaap_TypeOfArrangementAxis_xelb_LicenseAgreementMember_Z32Q8gr-WkyT8SrLpC8PYw", "decimals": "0", "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41201 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_mCG0ED9Af0iqn4XDayOyAQ", "decimals": "-5", "lang": null, "name": "xelb:AssetAcquisitionAdditionalConsiderationPayableToSeller", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_rNPb9xe_rEW_X-hcx6Y_Sg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_T7uCqRZKXEqbWgo57l-62w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41301 - Disclosure - Subsequent Events - Narrative (Details)", "menuCat": "Details", "order": "48", "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "shortName": "Subsequent Events - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_zXhOaHgIc0O_sxk0IDPEXw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9940202 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable 10K (Details)", "menuCat": "Details", "order": "49", "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails", "shortName": "Summary of Significant Accounting Policies - Accounts Receivable 10K (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_67ja7mRWdkm2HuGWUImdVg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_q_C06IJZpU67qmD6STFXug", "decimals": "-3", "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "menuCat": "Uncategorized", "order": "50", "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "shortName": "Pay vs Performance Disclosure", "subGroupType": "", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_SeCNijojcEut-GWvVdZTJQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": "-3", "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0NJnpjFWEU2Zh1FoX9Dl4Q", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation", "menuCat": "Notes", "order": "7", "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation", "shortName": "Nature of Operations, Background, and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_HjLYDZm3VU-pv_HQQ062IQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Equity Method Investment", "menuCat": "Notes", "order": "8", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment", "shortName": "Equity Method Investment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_HjLYDZm3VU-pv_HQQ062IQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Trademarks and Other Intangibles", "menuCat": "Notes", "order": "9", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles", "shortName": "Trademarks and Other Intangibles", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_OKsMvIPPtkiY6d38oEwfBQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 52, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document And Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "ecd_Additional402vDisclosureTextBlock": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "localname": "Additional402vDisclosureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToCompAmt": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "localname": "AdjToCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AdjToCompAxis": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "localname": "AdjToCompAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "localname": "AdjToNonPeoNeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToPeoCompFnTextBlock": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "localname": "AdjToPeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AggtErrCompAmt": { "auth_ref": [ "r705", "r716", "r726", "r751" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "localname": "AggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "auth_ref": [ "r708", "r719", "r729", "r754" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "localname": "AggtErrCompNotYetDeterminedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AllAdjToCompMember": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "localname": "AllAdjToCompMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllExecutiveCategoriesMember": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "localname": "AllExecutiveCategoriesMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllIndividualsMember": { "auth_ref": [ "r712", "r720", "r730", "r747", "r755", "r759", "r767" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "localname": "AllIndividualsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllTradingArrangementsMember": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "localname": "AllTradingArrangementsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "domainItemType" }, "ecd_AwardExrcPrice": { "auth_ref": [ "r762" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "localname": "AwardExrcPrice", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "perShareItemType" }, "ecd_AwardGrantDateFairValue": { "auth_ref": [ "r763" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "localname": "AwardGrantDateFairValue", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AwardTmgDiscLineItems": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "localname": "AwardTmgDiscLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMethodTextBlock": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "localname": "AwardTmgMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMnpiCnsdrdFlag": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "localname": "AwardTmgMnpiCnsdrdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardTmgMnpiDiscTextBlock": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "localname": "AwardTmgMnpiDiscTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgPredtrmndFlag": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "localname": "AwardTmgPredtrmndFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardUndrlygSecuritiesAmt": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "localname": "AwardUndrlygSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_AwardsCloseToMnpiDiscIndName": { "auth_ref": [ "r760" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "localname": "AwardsCloseToMnpiDiscIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTable": { "auth_ref": [ "r759" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "localname": "AwardsCloseToMnpiDiscTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "auth_ref": [ "r759" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "localname": "AwardsCloseToMnpiDiscTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ChangedPeerGroupFnTextBlock": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "localname": "ChangedPeerGroupFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CoSelectedMeasureAmt": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "localname": "CoSelectedMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_CoSelectedMeasureName": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "localname": "CoSelectedMeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "auth_ref": [ "r743" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "localname": "CompActuallyPaidVsNetIncomeTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompAnalysisTextBlock": { "auth_ref": [ "r705", "r716", "r726", "r751" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "localname": "ErrCompAnalysisTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompRecoveryTable": { "auth_ref": [ "r702", "r713", "r723", "r748" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "localname": "ErrCompRecoveryTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ExecutiveCategoryAxis": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "localname": "ExecutiveCategoryAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "auth_ref": [ "r709", "r720", "r730", "r755" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "auth_ref": [ "r709", "r720", "r730", "r755" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "auth_ref": [ "r709", "r720", "r730", "r755" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "auth_ref": [ "r709", "r720", "r730", "r755" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ForgoneRecoveryIndName": { "auth_ref": [ "r709", "r720", "r730", "r755" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "ForgoneRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_IndividualAxis": { "auth_ref": [ "r712", "r720", "r730", "r747", "r755", "r759", "r767" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "localname": "IndividualAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_InsiderTradingArrLineItems": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "localname": "InsiderTradingArrLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTradingPoliciesProcLineItems": { "auth_ref": [ "r701", "r771" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "localname": "InsiderTradingPoliciesProcLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "auth_ref": [ "r701", "r771" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "localname": "InsiderTrdPoliciesProcAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "booleanItemType" }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "auth_ref": [ "r701", "r771" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "textBlockItemType" }, "ecd_MeasureAxis": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "localname": "MeasureAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_MeasureName": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "localname": "MeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_MnpiDiscTimedForCompValFlag": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "localname": "MnpiDiscTimedForCompValFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_MtrlTermsOfTrdArrTextBlock": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "localname": "MtrlTermsOfTrdArrTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "textBlockItemType" }, "ecd_NamedExecutiveOfficersFnTextBlock": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "localname": "NamedExecutiveOfficersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonGaapMeasureDescriptionTextBlock": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "localname": "NonGaapMeasureDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonNeosMember": { "auth_ref": [ "r709", "r720", "r730", "r747", "r755" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "localname": "NonNeosMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "auth_ref": [ "r737" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoAvgTotalCompAmt": { "auth_ref": [ "r736" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "localname": "NonPeoNeoAvgTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoMember": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "localname": "NonPeoNeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonRule10b51ArrAdoptedFlag": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "localname": "NonRule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_NonRule10b51ArrTrmntdFlag": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "localname": "NonRule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_OtherPerfMeasureAmt": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "localname": "OtherPerfMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_OutstandingAggtErrCompAmt": { "auth_ref": [ "r707", "r718", "r728", "r753" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "localname": "OutstandingAggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryCompAmt": { "auth_ref": [ "r710", "r721", "r731", "r756" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "localname": "OutstandingRecoveryCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryIndName": { "auth_ref": [ "r710", "r721", "r731", "r756" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "OutstandingRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PayVsPerformanceDisclosureLineItems": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PayVsPerformanceDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_PeerGroupIssuersFnTextBlock": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "localname": "PeerGroupIssuersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_PeerGroupTotalShareholderRtnAmt": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "localname": "PeerGroupTotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoActuallyPaidCompAmt": { "auth_ref": [ "r737" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "localname": "PeoActuallyPaidCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoMember": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "localname": "PeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_PeoName": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "localname": "PeoName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_PeoTotalCompAmt": { "auth_ref": [ "r736" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "localname": "PeoTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PvpTable": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PvpTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PvpTableTextBlock": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "localname": "PvpTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "auth_ref": [ "r702", "r713", "r723", "r748" ], "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "localname": "RecoveryOfErrCompDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_RestatementDateAxis": { "auth_ref": [ "r703", "r714", "r724", "r749" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "localname": "RestatementDateAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_RestatementDeterminationDate": { "auth_ref": [ "r704", "r715", "r725", "r750" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "localname": "RestatementDeterminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "dateItemType" }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "auth_ref": [ "r711", "r722", "r732", "r757" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "localname": "RestatementDoesNotRequireRecoveryTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_Rule10b51ArrAdoptedFlag": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "localname": "Rule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_Rule10b51ArrTrmntdFlag": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "localname": "Rule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "auth_ref": [ "r706", "r717", "r727", "r752" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "localname": "StkPrcOrTsrEstimationMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TabularListTableTextBlock": { "auth_ref": [ "r746" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "localname": "TabularListTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TotalShareholderRtnAmt": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "localname": "TotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TradingArrAxis": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "localname": "TradingArrAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TradingArrByIndTable": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "localname": "TradingArrByIndTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrAdoptionDate": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "localname": "TrdArrAdoptionDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrDuration": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "localname": "TrdArrDuration", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "durationItemType" }, "ecd_TrdArrIndName": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "localname": "TrdArrIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrIndTitle": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "localname": "TrdArrIndTitle", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrSecuritiesAggAvailAmt": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "localname": "TrdArrSecuritiesAggAvailAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "sharesItemType" }, "ecd_TrdArrTerminationDate": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "localname": "TrdArrTerminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_UndrlygSecurityMktPriceChngPct": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "localname": "UndrlygSecurityMktPriceChngPct", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "pureItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r176", "r405", "r406", "r409", "r410", "r483", "r656", "r810", "r813", "r814" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r176", "r405", "r406", "r409", "r410", "r483", "r656", "r810", "r813", "r814" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r174", "r175", "r317", "r326", "r481", "r663", "r665" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r799", "r866" ], "lang": { "en-us": { "role": { "label": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r266", "r267", "r269" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r799" ], "lang": { "en-us": { "role": { "label": "Executive Officer [Member]" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r228", "r675", "r816", "r863", "r864" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r304", "r305", "r306", "r307", "r344", "r515", "r560", "r588", "r589", "r647", "r648", "r649", "r650", "r651", "r657", "r658", "r669", "r673", "r678", "r685", "r815", "r856", "r857", "r858", "r859", "r860", "r861" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r304", "r305", "r306", "r307", "r344", "r515", "r560", "r588", "r589", "r647", "r648", "r649", "r650", "r651", "r657", "r658", "r669", "r673", "r678", "r685", "r815", "r856", "r857", "r858", "r859", "r860", "r861" ], "lang": { "en-us": { "role": { "label": "Minimum", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r228", "r675", "r816", "r863", "r864" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r226", "r516", "r554", "r555", "r556", "r557", "r558", "r559", "r660", "r674", "r684", "r776", "r808", "r809", "r816", "r863" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r226", "r516", "r554", "r555", "r556", "r557", "r558", "r559", "r660", "r674", "r684", "r776", "r808", "r809", "r816", "r863" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r304", "r305", "r306", "r307", "r342", "r344", "r371", "r372", "r373", "r491", "r515", "r560", "r588", "r589", "r647", "r648", "r649", "r650", "r651", "r657", "r658", "r669", "r673", "r678", "r685", "r688", "r806", "r815", "r857", "r858", "r859", "r860", "r861" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r304", "r305", "r306", "r307", "r342", "r344", "r371", "r372", "r373", "r491", "r515", "r560", "r588", "r589", "r647", "r648", "r649", "r650", "r651", "r657", "r658", "r669", "r673", "r678", "r685", "r688", "r806", "r815", "r857", "r858", "r859", "r860", "r861" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r174", "r175", "r317", "r326", "r481", "r664", "r665" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r266", "r267", "r269" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r799", "r852" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r229", "r230" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r84", "r126" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Accrued income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r88", "r683", "r867" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r377", "r378", "r379", "r586", "r795", "r796", "r797", "r847", "r870" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Shares repurchased in exchange for withholding taxes" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r53", "r54", "r346" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Compensation expense related to stock options and restricted stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r375", "r380" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r152", "r231", "r282", "r285", "r288", "r862" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for Doubtful Accounts Receivable", "terseLabel": "Allowance for doubtful accounts receivable", "verboseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Write offs or recoveries" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r96", "r320", "r455", "r791" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "verboseLabel": "Amortization of deferred finance costs included in interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r5", "r41", "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization expense for intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionAxis": { "auth_ref": [ "r846" ], "lang": { "en-us": { "role": { "documentation": "Information by asset acquisition.", "label": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r846" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Earn-out balance before settlement", "verboseLabel": "Current portion of contingent obligations" } } }, "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r846" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Long-term portion of contingent obligations", "verboseLabel": "Contingent obligation" } } }, "localname": "AssetAcquisitionContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionDomain": { "auth_ref": [ "r846" ], "lang": { "en-us": { "role": { "documentation": "Asset acquisition.", "label": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r5", "r46" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r150", "r170", "r211", "r220", "r224", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r405", "r409", "r441", "r538", "r611", "r683", "r696", "r811", "r812", "r854" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r144", "r154", "r170", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r405", "r409", "r441", "r683", "r811", "r812", "r854" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r170", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r405", "r409", "r441", "r811", "r812", "r854" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Other Assets", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current Assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r62", "r63" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r30", "r146", "r661" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r30", "r105", "r168" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r1", "r105" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrants outstanding, exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r68", "r539", "r597" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingency", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r114", "r302", "r303", "r655", "r807" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "verboseLabel": "Shares of common stock reserved for issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r686", "r687", "r688", "r690", "r691", "r692", "r693", "r795", "r796", "r847", "r865", "r870" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r87", "r598" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r87", "r598", "r617", "r870", "r871" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Purchaseable stock", "verboseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r87", "r541", "r683" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.001 par value, 50,000,000 shares authorized, and 19,633,194 and 19,624,860 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r35", "r37", "r65", "r66", "r228", "r654" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r35", "r37", "r65", "r66", "r228", "r573", "r654" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r35", "r37", "r65", "r66", "r228", "r654", "r774" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Significant Contracts and Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContracts" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r35", "r37", "r65", "r66", "r228" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r34", "r35", "r37", "r38", "r65", "r124", "r654" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r35", "r37", "r65", "r66", "r228", "r654" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [ "r794" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.", "label": "Contractual Obligation", "terseLabel": "Contingent obligation" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r99", "r516" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r97" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "xelb_OperatingIncomeLossBeforeOtherExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total direct operating costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "verboseLabel": "Direct operating costs and expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r36", "r228" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r22", "r67", "r318" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Effective interest rate (as percentage)" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.", "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]" } } }, "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r382", "r383" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r5", "r120", "r134", "r395", "r396", "r793" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "verboseLabel": "Deferred income tax (benefit) provision" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r786" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r785" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue, current" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r786" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue, long-term liability" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r5", "r214" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r6", "r13" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposed of by Sale" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "auth_ref": [ "r2", "r70", "r77", "r112" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "terseLabel": "Amount received in cash" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "auth_ref": [ "r76" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "terseLabel": "Transaction expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings (Loss) Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r161", "r185", "r186", "r187", "r188", "r189", "r195", "r197", "r203", "r204", "r205", "r209", "r433", "r434", "r535", "r552", "r666" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net (loss) income per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "(Loss) earnings per common share attributable to Xcel Brands, Inc. stockholders:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r161", "r185", "r186", "r187", "r188", "r189", "r197", "r203", "r204", "r205", "r209", "r433", "r434", "r535", "r552", "r666" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net (loss) income per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Weighted average number of common shares outstanding:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r194", "r206", "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "verboseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther": { "auth_ref": [ "r844", "r845" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Other, Percent", "terseLabel": "Effect of reversal of valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionsOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r844", "r845" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "Effect of state taxes on effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Accrued payroll" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r376" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.", "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]" } } }, "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r10", "r139", "r157", "r158", "r159", "r177", "r178", "r179", "r182", "r190", "r192", "r210", "r275", "r281", "r339", "r377", "r378", "r379", "r391", "r392", "r414", "r416", "r417", "r418", "r419", "r421", "r432", "r446", "r447", "r448", "r449", "r450", "r451", "r474", "r563", "r564", "r565", "r586", "r639" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership interest" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Summarized Financial Information [Abstract]" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r217", "r264", "r784", "r804" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r136", "r268", "r271", "r773" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investment" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Summarized financial information for IM Topco" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r436", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Asset Purchase Agreement" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r436", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r283", "r284", "r289", "r290", "r291", "r292", "r293", "r294", "r321", "r336", "r422", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r551", "r670", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r800", "r801", "r802", "r803" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "presentationGuidance": "Weighted Average Amortization Period", "verboseLabel": "Estimated useful life of finite-lived intangible asset (in years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTrademarksAndOtherIntangibleAssets10kDetails", "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r148", "r297" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "verboseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r295", "r296", "r297", "r298", "r517", "r521" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r111", "r521" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Gross Carrying Amount (definite-lived)" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r42", "r44" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r111", "r517" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r791" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Gain on sale of majority interest in Isaac Mizrahi brand", "terseLabel": "Gain on sale of majority interest in Isaac Mizrahi brand" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [ "r461" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.", "label": "Gain (Loss) on Termination of Lease", "negatedLabel": "Gain on settlement of lease liability", "terseLabel": "Gain on settlement of lease liability" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r5", "r47", "r48" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on early extinguishment of debt", "negatedTerseLabel": "Loss on early extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "Trademarks and Other Intangibles" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r345", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r345", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r98", "r170", "r211", "r219", "r223", "r225", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r441", "r668", "r811" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "xelb_OperatingIncomeLossBeforeOtherExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r93", "r130", "r211", "r219", "r223", "r225", "r536", "r547", "r668" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r122", "r170", "r181", "r211", "r219", "r223", "r225", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r434", "r441", "r547", "r668", "r811" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r5", "r94", "r129", "r215", "r264", "r546" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Undistributed proportional share of net loss of equity method investee", "verboseLabel": "Loss from equity method investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r9", "r13", "r17", "r70", "r71", "r72", "r73", "r74", "r75", "r78", "r79", "r80", "r113" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r299", "r301", "r624" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r301", "r624" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r171", "r381", "r386", "r387", "r388", "r393", "r397", "r398", "r399", "r580" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r133", "r135", "r191", "r192", "r216", "r384", "r394", "r553" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax (benefit) provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r29", "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid during the period for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r4" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r659" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r4" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r775", "r790" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Lease-related assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r4" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r4" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "verboseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r4" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other current and non-current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r198", "r199", "r200", "r205" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants", "terseLabel": "Add: Effect of warrants (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r198", "r199", "r201", "r205", "r348" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "verboseLabel": "Add: Effect of stock options (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r147" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Gross Carrying Amount, Total" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r40", "r43" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Trademarks and other intangibles, net", "totalLabel": "Net Carrying Amount, Total" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Copyrights and other intellectual property" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestAndDebtExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest and Debt Expense [Abstract]", "verboseLabel": "Interest and finance (income) expense" } } }, "localname": "InterestAndDebtExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r102", "r319", "r322", "r671", "r672" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense - term loan debt" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r132" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedTotalLabel": "Total interest and finance (income) expense" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r163", "r166", "r167" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r153", "r662", "r683" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "verboseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r789" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Salaries Benefits And Employment Taxes", "verboseLabel": "Salaries, benefits and employment taxes" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r851" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Maturities of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r469" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r469" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r469" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r469" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r469" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r851" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "verboseLabel": "2023 (April 1 through December 31)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r469" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: Discount" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r170", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r406", "r409", "r410", "r441", "r596", "r667", "r696", "r811", "r854", "r855" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r92", "r128", "r544", "r683", "r792", "r805", "r849" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r145", "r170", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r406", "r409", "r410", "r441", "r683", "r811", "r854", "r855" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r16", "r81", "r82", "r83", "r85", "r170", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r406", "r409", "r410", "r441", "r811", "r854", "r855" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "verboseLabel": "Long-Term Liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r817" ], "lang": { "en-us": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "Net licensing revenue" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]", "verboseLabel": "Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r26", "r127", "r170", "r270", "r308", "r310", "r311", "r312", "r315", "r316", "r441", "r543", "r600" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Ownership interest" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r165" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r165" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r105", "r106", "r107" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r95", "r107", "r131", "r143", "r155", "r156", "r159", "r170", "r181", "r185", "r186", "r187", "r188", "r191", "r192", "r202", "r211", "r219", "r223", "r225", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r434", "r441", "r550", "r619", "r637", "r638", "r668", "r694", "r811" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "Net (loss) income attributable to Xcel Brands, Inc. stockholders", "verboseLabel": "Net (loss) income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r61", "r123", "r155", "r156", "r191", "r192", "r549", "r788" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net loss attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [ "r137", "r138", "r139", "r140", "r141", "r180", "r181", "r182", "r183", "r184", "r187", "r193", "r209", "r232", "r233", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r300", "r377", "r378", "r379", "r389", "r390", "r391", "r392", "r400", "r401", "r402", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r439", "r440", "r442", "r443", "r444", "r445", "r453", "r454", "r456", "r457", "r458", "r459", "r470", "r471", "r472", "r473", "r474", "r518", "r519", "r520", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r576" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r32", "r137", "r138", "r139", "r140", "r141", "r180", "r181", "r182", "r183", "r184", "r187", "r193", "r209", "r232", "r233", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r300", "r377", "r378", "r379", "r389", "r390", "r391", "r392", "r400", "r401", "r402", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r439", "r440", "r442", "r443", "r444", "r445", "r453", "r454", "r456", "r457", "r458", "r459", "r470", "r471", "r472", "r473", "r474", "r518", "r519", "r520", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r576" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r56", "r339", "r795", "r796", "r797", "r870" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r211", "r219", "r223", "r225", "r668" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other operating costs and expenses (income)" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r850" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r463" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r463" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations", "verboseLabel": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r463" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current portion of lease liabilities", "verboseLabel": "Long-term portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r464", "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash payments for operating lease expense" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r462" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r468", "r682" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r467", "r682" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations, Background, and Basis of Presentation [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r69", "r121", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Nature of Operations, Background, and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r149" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherExpenseMember": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other expense.", "label": "Other Expense [Member]", "terseLabel": "Other expense (income), including non-cash expenses" } } }, "localname": "OtherExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]", "terseLabel": "Other income" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Other Noncash Expense" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r151", "r606" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Due from related party" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r27" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Shares repurchased including vested restricted stock in exchange for withholding taxes" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r3" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedLabel": "Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r104" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r86", "r324" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r86", "r598" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r86", "r324" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r86", "r598", "r617", "r870", "r871" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r86", "r540", "r683" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r787" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r103" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "verboseLabel": "Net proceeds from sale of assets" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r674" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Net sales" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r694", "r868", "r869" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "verboseLabel": "Legal and agent fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r143", "r155", "r156", "r164", "r170", "r181", "r191", "r192", "r211", "r219", "r223", "r225", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r404", "r407", "r408", "r434", "r441", "r536", "r548", "r585", "r619", "r637", "r638", "r668", "r680", "r681", "r695", "r788", "r811" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Net loss", "terseLabel": "Net loss", "totalLabel": "Net (loss) income", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r7", "r537", "r545", "r683" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r162", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for Doubtful Accounts", "verboseLabel": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r343", "r478", "r479", "r591", "r592", "r593", "r594", "r595", "r616", "r618", "r646" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyMember": { "auth_ref": [ "r172", "r173", "r478", "r479", "r480", "r481", "r591", "r592", "r593", "r594", "r595", "r616", "r618", "r646" ], "lang": { "en-us": { "role": { "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.", "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r343", "r478", "r479", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r591", "r592", "r593", "r594", "r595", "r616", "r618", "r646", "r853" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r475", "r476", "r477", "r479", "r482", "r581", "r582", "r583", "r622", "r623", "r624", "r643", "r645" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r28", "r578" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Payment of long-term debt", "terseLabel": "Repayment of principal", "verboseLabel": "Payment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r89", "r117", "r542", "r567", "r572", "r579", "r599", "r683" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r139", "r177", "r178", "r179", "r182", "r190", "r192", "r275", "r281", "r377", "r378", "r379", "r391", "r392", "r414", "r417", "r418", "r421", "r432", "r563", "r565", "r586", "r870" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r212", "r213", "r218", "r221", "r222", "r226", "r227", "r228", "r340", "r341", "r516" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net revenue", "verboseLabel": "Licensing revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r160", "r170", "r212", "r213", "r218", "r221", "r222", "r226", "r227", "r228", "r270", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r441", "r536", "r811" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues", "verboseLabel": "Revenue from services provided" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense", "terseLabel": "Recognized royalty expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyGuaranteesCommitmentsAmount": { "auth_ref": [ "r522" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount the entity has committed to make for future royalty guarantees.", "label": "Royalty Guarantees, Commitments, Amount", "terseLabel": "Royalty guarantees" } } }, "localname": "RoyaltyGuaranteesCommitmentsAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable": { "auth_ref": [ "r8", "r49", "r51", "r118" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]", "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of the basic and diluted net loss per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "verboseLabel": "Schedule of Trademarks and Other Intangibles" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r345", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r11", "r12", "r52" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "verboseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "terseLabel": "Summary of Stock Option Activity for Non-Vested Options" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "verboseLabel": "Summary of Warrant Activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r101" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "verboseLabel": "Other selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r4" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Operating cost", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Other disclosures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "Expired/Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Other than Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)", "verboseLabel": "Number of shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r345", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stockholders' Equity" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of common stock eligible for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "verboseLabel": "Shares are granted available for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r824" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Expired/Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r824" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "All Award Types", "terseLabel": "All Award Types" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Employees" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable Weighted Average Remaining Contractual Life (in Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Options", "verboseLabel": "Number of Options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance (in dollars per share)", "periodStartLabel": "Beginning Balance (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "verboseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Outstanding Weighted Average Remaining Contractual Life (in Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested (in shares)", "terseLabel": "Vested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityOutstandingAndVestingOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balances (in shares)", "periodStartLabel": "Balances (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedTerseLabel": "Shares repurchased in exchange for withholding taxes (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r10", "r25", "r139", "r157", "r158", "r159", "r177", "r178", "r179", "r182", "r190", "r192", "r210", "r275", "r281", "r339", "r377", "r378", "r379", "r391", "r392", "r414", "r416", "r417", "r418", "r419", "r421", "r432", "r446", "r447", "r448", "r449", "r450", "r451", "r474", "r563", "r564", "r565", "r586", "r639" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r177", "r178", "r179", "r210", "r516", "r577", "r587", "r590", "r591", "r592", "r593", "r594", "r595", "r598", "r601", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r610", "r612", "r613", "r614", "r615", "r616", "r618", "r620", "r621", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r639", "r689" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r177", "r178", "r179", "r210", "r516", "r577", "r587", "r590", "r591", "r592", "r593", "r594", "r595", "r598", "r601", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r610", "r612", "r613", "r614", "r615", "r616", "r618", "r620", "r621", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r639", "r689" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Shares issued related to/in connection with stock grant" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued to consultant in connection with Isaac Mizrahi sale transaction" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r10", "r117" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Shares issued to consultant in connection with stock grant (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Shares issued related to/in connection with stock grant" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r10", "r86", "r87", "r117", "r357" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period", "terseLabel": "Shares issued on exercise of stock options, net (in shares)", "verboseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Shares issued to consultant in connection with Isaac Mizrahi sale transaction" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r10", "r86", "r87", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Shares issued to consultant in connection with stock grant" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r10", "r25", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued on exercise of stock options, net" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r87", "r90", "r91", "r109", "r600", "r617", "r640", "r641", "r683", "r696", "r792", "r805", "r849", "r870" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Xcel Brands, Inc. stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r56", "r57", "r60", "r139", "r140", "r158", "r177", "r178", "r179", "r182", "r190", "r275", "r281", "r339", "r377", "r378", "r379", "r391", "r392", "r414", "r416", "r417", "r418", "r419", "r421", "r432", "r446", "r447", "r451", "r474", "r564", "r565", "r584", "r600", "r617", "r640", "r641", "r652", "r695", "r792", "r805", "r849", "r870" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balances", "periodStartLabel": "Balances", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r116", "r169", "r323", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r337", "r339", "r423", "r642", "r644", "r653" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r452", "r484" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r452", "r484" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events." } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks (finite-lived)" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r321", "r336", "r422", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r551", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r800", "r801", "r802", "r803" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r58", "r405", "r406", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Primary Beneficiary" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r686", "r687", "r690", "r691", "r692", "r693" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r848" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r196", "r205" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted average number of shares outstanding", "verboseLabel": "Diluted weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r195", "r205" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.", "label": "Write off of Deferred Debt Issuance Cost", "terseLabel": "Unamortized deferred finance costs" } } }, "localname": "WriteOffOfDeferredDebtIssuanceCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Accounts Receivable [Abstract]" } } }, "localname": "AccountsReceivableAbstract", "nsuri": "http://www.xcelbrands.com/20230630", "xbrltype": "stringItemType" }, "xelb_AccountsReceivableAssignedToThirdPartyAgentForCollection": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding balance in accounts receivables which is assigned to third party agent for collection purposes.", "label": "Accounts Receivable, Assigned to Third Party Agent for Collection", "terseLabel": "Accounts receivable, assigned to third party agent for collection" } } }, "localname": "AccountsReceivableAssignedToThirdPartyAgentForCollection", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AccountsReceivableCollectionAgentFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fees paid to agent for collection of accounts receivables.", "label": "Accounts Receivable, Collection Agent Fees", "terseLabel": "Accounts receivable, collection agent fees" } } }, "localname": "AccountsReceivableCollectionAgentFees", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivable10kDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AccountsReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable.", "label": "Accounts Receivable [Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableTextBlock", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivable" ], "xbrltype": "textBlockItemType" }, "xelb_AcquisitionsAndDivestituresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Acquisitions, Divestitures and Variable Interest Entities[Abstract]" } } }, "localname": "AcquisitionsAndDivestituresAbstract", "nsuri": "http://www.xcelbrands.com/20230630", "xbrltype": "stringItemType" }, "xelb_AdditionalRoyaltyPayableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional amount of time that that royalties will be payable.", "label": "Additional Royalty Payable Term", "terseLabel": "Additional royalty payable term" } } }, "localname": "AdditionalRoyaltyPayableTerm", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "durationItemType" }, "xelb_AdjustmentToPurchasePricePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount payable as adjustment to purchase price previously received by the company.", "label": "Adjustment to Purchase Price Payable", "terseLabel": "Adjustments to purchase price payable" } } }, "localname": "AdjustmentToPurchasePricePayable", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AllowanceForDoubtfulAccountsReceivableWriteOffAndExpense": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs charged against the allowance and expense for expected credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable, Write-Off And Expense", "terseLabel": "Provision for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffAndExpense", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionAdditionalConsiderationPayableToSeller": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of additional consideration payable to seller.", "label": "Asset Acquisition, Additional Consideration Payable To Seller", "terseLabel": "Additional consideration is payable to the seller" } } }, "localname": "AssetAcquisitionAdditionalConsiderationPayableToSeller", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionContingentObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Contingent Obligation", "label": "Asset Acquisition, Contingent Obligation", "verboseLabel": "Contingent obligation (Lori Goldstein Earn-Out)" } } }, "localname": "AssetAcquisitionContingentObligation", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionPrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of purchase price of asset acquired.", "label": "Asset Acquisition Price", "terseLabel": "Total purchase price" } } }, "localname": "AssetAcquisitionPrice", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionRoyaltiesTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Royalties Term", "label": "Asset Acquisition, Royalties Term", "terseLabel": "Royalties earned" } } }, "localname": "AssetAcquisitionRoyaltiesTerm", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "xelb_AssetAcquisitionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisitions [Abstract]", "label": "Asset Acquisitions [Abstract]" } } }, "localname": "AssetAcquisitionsAbstract", "nsuri": "http://www.xcelbrands.com/20230630", "xbrltype": "stringItemType" }, "xelb_AssetAcquisitionsContingentConsiderationAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the maximum aggregate amount of contingent considerations.", "label": "Asset Acquisitions, Contingent Consideration, Amount", "terseLabel": "Contingent consideration" } } }, "localname": "AssetAcquisitionsContingentConsiderationAmount", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "xelb_BusinessVentureAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Business Venture Agreement.", "label": "Business Venture Agreement [Member]", "terseLabel": "Business Venture Agreement" } } }, "localname": "BusinessVentureAgreementMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "domainItemType" }, "xelb_ClassOfWarrantOrRightExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercisable.", "label": "Class Of Warrant or Right, Exercisable", "terseLabel": "Exercisable (in shares)" } } }, "localname": "ClassOfWarrantOrRightExercisable", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightExercisableInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant date fair value of warrants exercisable.", "label": "Class of Warrant or Right Exercisable In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercisable, ending balance (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisableInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of the exercisable warrants.", "label": "Class of Warrant or Right, Exercisable In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (in Years), Exercisable" } } }, "localname": "ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "xelb_ClassOfWarrantOrRightExercisableIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The exercisable intrinsic value of the warrants.", "label": "Class of Warrant or Right, Exercisable Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "localname": "ClassOfWarrantOrRightExercisableIntrinsicValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "xelb_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were exercised during the reporting period.", "label": "Class Of Warrant Or Right, Exercised", "terseLabel": "Exercised (in shares)" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Exercised In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Exercised In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightExpiredForfeitedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired, forfeited in period weighted average grant date fair value.", "label": "Class Of Warrant Or Right Expired, Forfeited In Period Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExpiredForfeitedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were forfeited during the reporting period.", "label": "Class Of Warrant Or Right, Forfeited", "terseLabel": "Expired/Forfeited (in shares)" } } }, "localname": "ClassOfWarrantOrRightForfeited", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were granted during the reporting period.", "label": "Class Of Warrant Or Right, Granted", "terseLabel": "Granted (in shares)" } } }, "localname": "ClassOfWarrantOrRightGranted", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life (in Years), Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "xelb_ClassOfWarrantOrRightOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding Intrinsic Value", "label": "Class Of Warrant Or Right, Outstanding Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstandingIntrinsicValue", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "xelb_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Commitments and Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "xelb_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from commitments and contingencies.", "label": "Commitments and Contingencies [Table]", "terseLabel": "Commitments and Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "xelb_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Consultant" } } }, "localname": "ConsultantMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "domainItemType" }, "xelb_ConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to consultants.", "label": "Consultants" } } }, "localname": "ConsultantsMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "xelb_CostsAndExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Costs and Expenses [Member]", "terseLabel": "Costs and Expenses" } } }, "localname": "CostsAndExpensesMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "xelb_DebtInstrumentPrepaymentFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of prepayment fee in a debt instrument.", "label": "Debt Instrument, Prepayment Fee", "terseLabel": "Prepayment fee" } } }, "localname": "DebtInstrumentPrepaymentFee", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_DeferredRevenueRecognitionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time that the deferred revenue will be recognized over.", "label": "Deferred Revenue, Recognition Period", "terseLabel": "Recognition period of deferred revenue" } } }, "localname": "DeferredRevenueRecognitionPeriod", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails" ], "xbrltype": "durationItemType" }, "xelb_EmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee [Member]", "label": "Employee" } } }, "localname": "EmployeeMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "xelb_EquityIncentivePlan2011Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2011 Equity Incentive Plan.", "label": "2011 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlan2011Member", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "xelb_EquityIncentivePlan2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2021 Equity Incentive Plan.", "label": "2021 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlan2021Member", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Trademarks and Other Intangibles" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of finite-lived and indefinite-lived intangible assets, excluding goodwill, in total and by major class.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "xelb_GainLossOnSaleOfLimitedPartnerOwnershipInterest": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale of limited partner ownership interest.", "label": "Gain Loss on Sale of Limited Partner Ownership Interest", "negatedLabel": "Gain on sale of limited partner ownership interest" } } }, "localname": "GainLossOnSaleOfLimitedPartnerOwnershipInterest", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_HalstonBrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the Halston Brand (the \"Halston License\").", "label": "Halston Brand [Member]", "terseLabel": "Halston License" } } }, "localname": "HalstonBrandMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_IMTopcoLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to IM Topco, LLC.", "label": "IM Topco, LLC" } } }, "localname": "IMTopcoLLCMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_ImTopcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM Topco.", "label": "IM Topco [Member]" } } }, "localname": "ImTopcoMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "xelb_ImWhpLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM WHP LLC.", "label": "WHP" } } }, "localname": "ImWhpLlcMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "domainItemType" }, "xelb_IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Isaac Mizrahi Brand trademarks and other intellectual property.", "label": "IM Intellectual Property", "terseLabel": "IM Brand trademarks and other intellectual property rights" } } }, "localname": "IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_IsaacMizrahiSaleTransactionWithImTopcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Isaac Mizrahi sale transaction with IM Topco.", "label": "Isaac Mizrahi Sale Transaction with IM Topco [Member]", "terseLabel": "Isaac Mizrahi sale transaction with IM Topco" } } }, "localname": "IsaacMizrahiSaleTransactionWithImTopcoMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_LeaseSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease settlement expense.", "label": "Lease Settlement Expense", "terseLabel": "Lease settlement expense" } } }, "localname": "LeaseSettlementExpense", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_LeaseSettlementLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability related to the settlement of the lease.", "label": "Lease Settlement Liability", "terseLabel": "Lease settlement liability" } } }, "localname": "LeaseSettlementLiability", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_LeaseSettlementPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease settlement payable.", "label": "Lease Settlement Payable", "terseLabel": "Lease settlement payable" } } }, "localname": "LeaseSettlementPayable", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_LicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to license agreement.", "label": "License Agreement [Member]", "terseLabel": "License Agreement" } } }, "localname": "LicenseAgreementMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "xelb_LongabergerLicensingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Longaberger Licensing, LLC [Member]", "label": "Longaberger Licensing, LLC" } } }, "localname": "LongabergerLicensingLLCMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "xelb_LoriGoldsteinBrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Lori Goldstein Brand.", "label": "Lori Goldstein Brand" } } }, "localname": "LoriGoldsteinBrandMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_LossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Loss From Equity Method Investments", "terseLabel": "Loss from equity method investment" } } }, "localname": "LossFromEquityMethodInvestments", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_NetProceedsFromSaleOfMajorityInterestInInvestingActivity": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net proceeds from sale of majority interest in investing activity.", "label": "Net Proceeds from Sale of Majority Interest in Investing Activity", "terseLabel": "Net proceeds from sale of majority interest in Isaac Mizrahi brand" } } }, "localname": "NetProceedsFromSaleOfMajorityInterestInInvestingActivity", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xelb_NonManagementDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Management Directors" } } }, "localname": "NonManagementDirectorsMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "xelb_NumberOfConsecutiveQuartersForRoyaltyPayableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive quarters for royalty payable term.", "label": "Number of Consecutive Quarters for Royalty Payable Term", "terseLabel": "Number of consecutive quarters for royalty payable term" } } }, "localname": "NumberOfConsecutiveQuartersForRoyaltyPayableTerm", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "xelb_OperatingIncomeLossBeforeOtherExpense": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before the inclusion of other expenses.", "label": "Operating Income Loss Before Other Expense", "totalLabel": "Operating loss before other operating costs and expenses (income)" } } }, "localname": "OperatingIncomeLossBeforeOtherExpense", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_OtherExpenseDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount other expense incurred on debt.", "label": "Other Expense, Debt", "terseLabel": "Other costs" } } }, "localname": "OtherExpenseDebt", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_OtherInterestAndFinanceChargesIncomeNet": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of other interest and finance charges (income), net incurred during the period.", "label": "Other Interest And Finance Charges (Income) Net", "terseLabel": "Other interest and finance charges, net" } } }, "localname": "OtherInterestAndFinanceChargesIncomeNet", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_PercentageOfNetCashFlowDistributableToMembers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of net cash flow distributable to members.", "label": "Percentage of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members (in percent)" } } }, "localname": "PercentageOfNetCashFlowDistributableToMembers", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "percentItemType" }, "xelb_ProceedsFromEarnOutPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of proceeds from earn out payment.", "label": "Proceeds from Earn Out Payment", "terseLabel": "WHP earned in cashflow" } } }, "localname": "ProceedsFromEarnOutPayment", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_QOptixLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Q Optix, LLC.", "label": "Q Optix, LLC" } } }, "localname": "QOptixLlcMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "xelb_QurateRetailGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Qurate Retail Group.", "label": "Qurate" } } }, "localname": "QurateRetailGroupMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsQurateAgreementsDetails" ], "xbrltype": "domainItemType" }, "xelb_ReconciliationToAmountsOnConsolidatedBalanceSheetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "", "label": "Reconciliation to amounts on consolidated balance sheets [Abstract]", "verboseLabel": "Reconciliation to amounts on consolidated balance sheets:" } } }, "localname": "ReconciliationToAmountsOnConsolidatedBalanceSheetsAbstract", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "xelb_ReductionInOperatingExpensesOverNextYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for operating activities to be reduced over the next year. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Reduction in Operating Expenses Over Next Year", "terseLabel": "Reduction in operating expenses" } } }, "localname": "ReductionInOperatingExpensesOverNextYear", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "xelb_ReductionInPayrollCostsOverNextYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees to be reduced over the next year. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Reduction in Payroll Costs Over the Next Year", "terseLabel": "Reduction in payroll costs" } } }, "localname": "ReductionInPayrollCostsOverNextYear", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "xelb_RoyaltyPayableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of time that royalties will be payable.", "label": "Royalty Payable Term", "terseLabel": "Royalty payable term" } } }, "localname": "RoyaltyPayableTerm", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSignifcantContractsAndConcentrationsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "durationItemType" }, "xelb_ServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Services Agreement.", "label": "Services Agreement [Member]", "terseLabel": "Services Agreement" } } }, "localname": "ServicesAgreementMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "xelb_ThresholdAmountOfNetCashFlowDistributableToMembers": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Threshold amount of net cash flow distributable to members.", "label": "Threshold Amount of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members" } } }, "localname": "ThresholdAmountOfNetCashFlowDistributableToMembers", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "monetaryItemType" }, "xelb_UnexercisedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information relating to unexercised stock options.", "label": "Unexercised Stock Options" } } }, "localname": "UnexercisedStockOptionsMember", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "xelb_WorkingCapitalNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net of current asset and liabilities.", "label": "Working Capital, Net", "terseLabel": "Working capital, Net" } } }, "localname": "WorkingCapitalNet", "nsuri": "http://www.xcelbrands.com/20230630", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org//350/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org//323/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "50", "Subparagraph": "(a)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479092/842-20-40-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147482943/710-10-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483119/928-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4F", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r697": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r698": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r699": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r701": { "Name": "Form 20-F", "Paragraph": "a", "Publisher": "SEC", "Section": "16", "Subsection": "J", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r702": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r703": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r704": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "A", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r705": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "B", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r706": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "C", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r707": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "D", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r708": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "E", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r709": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "iii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r711": { "Name": "Form 20-F", "Paragraph": "2", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r712": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r713": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r714": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r715": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r716": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r717": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r718": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r719": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r721": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r722": { "Name": "Form 40-F", "Paragraph": "b", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r723": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r724": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r725": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r726": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r727": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r728": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r729": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r731": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r732": { "Name": "Form N-CSR", "Paragraph": "b", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r733": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r734": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r735": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r736": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r737": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r738": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r739": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "vi", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "3", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r741": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "4", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r742": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r743": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r744": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r745": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r746": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r747": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r748": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r749": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r751": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "B", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r752": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r753": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r754": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r755": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r756": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r757": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r758": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r759": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r761": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r762": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r763": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r764": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "F", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r765": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r766": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r767": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "A", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r768": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "B", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r769": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "C", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "D", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r771": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r772": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(f)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r781": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r782": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 69 0001558370-23-014913-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-23-014913-xbrl.zip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end